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Carbohydrates are essential biomolecules in all living organisms. Besides serving 
as energy storage and structural building blocks in primary metabolism, carbohydrates 
represent the building blocks for numerous bioactive natural products. The presence of 
sugar moieties in secondary metabolites are important for the biological properties of these 
natural products. Thus, the study of biosynthetic pathways involving carbohydrate 
secondary metabolism can reveal some intriguing enzymatic transformations that lead to 
remarkable structural diversity. Understanding these pathways and the enzymes they 
contain can provide new insights for pathway engineering and the production of novel 
sugar structures. 
The radical S-adenosyl-L-methionine (SAM) enzymes are distinguished by their 
unique chemistry that results in the reductive homolysis of SAM to generate a reactive 5′-
deoxyadenosyl radical. Subsequent formation of a substrate radical intermediate by this 
radical initiator permits a diverse set of biotransformations. DesII belongs to the radical 
SAM enzyme superfamily, and is involved in the biosynthesis of TDP-desosamine in 
Streptomyces venezuelae. DesII catalyzes the deamination of its biosynthetic substrate (i.e., 
TDP-4,6-dideoxy-3-keto-D-glucose), whereas it promotes an oxidative dehydrogenation 
reaction when the C4 amino group of the substrate is replaced by a hydroxyl group (i.e., 
 vi 
TDP-D-quinovose). Control of the radical intermediate resulting in two distinct reaction 
outcomes has been a primary focus of this research. It has been proposed that the orbital 
geometry of the radical intermediates is an important factor in determining whether the 
enzyme functions as a lyase or a dehydrogenase. To investigate this hypothesis, several 
substrate analogs with altered stereochemistry of ring substituents were tested as potential 
substrates for DesII and the reaction products were characterized. While DesII deaminates 
the C4 axial amino substituent as it does with the C4 equatorial amino group, inversion of 
stereochemistry of a hydroxyl group at C4 allows dehydration to take place. These results 
support the working hypothesis that the stereochemical configuration of substrate radical 
in the active site plays an important role in controlling the partitioning into different 
reaction pathways.  
Formycin A and coformycin are nucleoside antibiotics produced by Nocardia 
interforma and Streptomyces kaniharaensis. Their biosynthetic pathways are of particular 
interest because of their unusual structural features such as the pyrazolopyrimidine 
nucleobase with a C-glycosidic linkage in formycin A and the 1,3-diazepine ring in 
coformycin. Genomic analysis of producing strain suggested that the pyrimidine ring of 
formycin A is formed in a pathway analogous to that for purines, which led to the 
identification of a potential biosynthetic gene cluster and pathway for formycin A. 
Conversion of the putative intermediate, carboxyaminopyrazole ribonucleotide, in this 
pathway to the final product was demonstrated to be catalyzed by enzymes encoded in the 
for cluster as proposed. It was also shown that one gene adjacent to the formycin A gene 
cluster encodes a reductase that catalyzes the last step in the biosynthesis of coformycin. 
This study aims to elucidate the biosynthetic pathways of formycin A and coformycin with 
an emphasis on the formation of pyrazolopyrimidine moiety and C-glycosidic bond. 
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Chapter 1:  Background and Significance 
 
1.1 RADICAL SAM ENZYMES IN THE BIOSYNTHESIS OF CARBOHYDRATES 
 
1.1.1 Radical SAM Enzymes 
Radical S-adenosyl-L-methionine (SAM) enzymes represent one of the most 
rapidly growing enzyme superfamilies found across all kingdom.1-3 Radical SAM enzymes 
utilize a [4Fe–4S] cluster to initiate a reductive homolytic cleavage of SAM (1) that 
generates a 5′-deoxyadenosyl radical (2, 5′-dAdo•) and methionine (3) (Figure 1-1). The 
5′-deoxyadenosyl radical (2) subsequently abstracts a hydrogen from the substrate to 
produce 5′-deoxyadenosine (4, 5′-dAdo) and a substrate radical (denoted R• in Figure 1-1) 
that can undergo a variety of radical-mediated transformations. As the hydrogen atom can 
be abstracted from an unactivated C–H bond, these enzymes are capable of catalyzing a 
diverse set of reactions that would be challenging to accomplish via Lewis acid/base 
chemistry alone. Radical SAM enzymes typically contain three conserved cysteine 
residues coordinated to the [4Fe–4S] cluster, usually in a characteristic CX3CX2C motif, 
although the number of residues between cysteines can be varied. The reactions catalyzed 
by radical SAM enzymes include but are not limited to methylation, oxidation, sulfur 
insertion, and complex rearrangements. This class of enzymes have been extensively 
reviewed elsewhere.3 
 2 
 
Figure 1-1. Reductive homolysis of SAM (1) during the catalytic cycle of radical SAM 
enzymes. 
 
1.1.2 Radical-Mediated Reactions in the Biosynthesis of Carbohydrates 
Carbohydrates play a vital role in all biological systems, with prominent roles in 
energy storage and the structure of nucleic acids. In addition to primary metabolism, sugar 
biosynthesis is also an essential part of secondary metabolism, because the biological 
activities of many antibacterial and antiproliferative natural products depend on the 
presence of carbohydrate appendages.4 Recent studies have shown that radical SAM 
chemistry is often employed to achieve complex transformations during the biosynthesis 
of unusual carbohydrates in nature.5 The utilization of radical SAM enzymes in the 
biosynthesis of glycosylated natural product contributes to the structural diversity of the 
sugar products resulting from radical-mediated reactions. Mechanistic study of these 
enzymes can therefore help to unravel the principles by which reactive radical 
intermediates are generated and controlled in order to effect catalysis. Moreover, 
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understanding the biosynthetic pathways of unusual carbohydrates would offer the 
opportunity to exploit their biosynthetic machinery to generate novel sugar structures with 
enhanced biological activities. 
BtrN is a well characterized radical SAM enzyme which is involved in the 
biosynthetic pathway of butirosin (10). Butirosin is an aminoglycoside antibiotic produced 
by Bacillus circulans. It contains a 2-deoxystreptamine (9, DOS) aglycone core structure 
that is also found in kanamycin, tobramycin, and gentamicin.6 The discovery of the 
biosynthetic gene cluster of butirosin had allowed the elucidation of DOS biosynthesis, and 
the results showed that the pathway involves a 2-deoxy-scyllo-inosose (6, DOI) synthase 
BtrC, an aminotransferase BtrS, and a dehydrogenase BtrN (Figure 1-2).7,8 The radical 
SAM enzyme BtrN was shown to be responsible for the production of 3-amino-2,3-
dideoxy-scyllo-inosose (8, amino-DOI) from 2-deoxy-scyllo-inosamine (7, DOIA).9 The 
dehydrogenation reaction catalyzed by BtrN is distinguished from the nicotinamide-
dependent dehydrogenation reaction commonly found in the biosynthesis of other DOS-
containing aminoglycosides, as catalysis by BtrN involves radical intermediates. 
 
 
Figure 1-2. Biosynthetic pathway of butirosin (10). 
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Figure 1-3. Proposed mechanism of BtrN-catalyzed dehydrogenation reaction of 7. 
 
The reaction mechanism of BtrN has been studied in vitro by biochemical 
characterization and electron paramagnetic resonance (EPR) spectroscopy (Figure 1-3).10 
The reaction is initiated by electron transfer from the reduced [4Fe–4S]1+ cluster to SAM 
upon binding of SAM and the substrate DOIA (7) in the enzyme active site. Homolysis of 
the C–S bond of SAM generates 5′-deoxyadenosyl radical (2) that abstracts a hydrogen at 
C3 of 7. Following the formation of the substrate radical, the dehydrogenation proceeds 
via one electron transfer back to the oxidized [4Fe–4S]2+ cluster to convert the hydroxyl 
group at C3 to the corresponding keto group. Iron/sulfur titration, mutation, Mössbauer 
spectroscopy studies11 along with X-ray crystallography12 have revealed the presence of an 
additional auxiliary [4Fe–4S] cluster in the BtrN active site. Direct electrochemical 
measurement of redox potentials for the [4Fe–4S] clusters have also shown that the 
auxiliary cluster exhibits an unusually low potential.13 While the role of the second cluster 
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is uncertain, it may participate in catalysis as an electron acceptor during oxidation of the 
substrate radical (see Figure 1-3). 
 
 
 
 
Figure 1-4. Methylation by GenD1 and GenK. 
 
Some radical SAM enzymes require cobalamin as an additional cofactor.14 GenD1 
and GenK are cobalamin-dependent radical SAM enzymes involved in the biosynthesis of 
gentamicins in Micromonospora echinospora.15 Gentamicins are clinically important 
aminoglycoside antibiotics that inhibit protein synthesis and are used in the treatment of 
Gram-negative bacterial infections.6 During the biogenesis of gentamicins, GenD116 and 
GenK17 catalyze the methylation of C-4′′ of gentamicin A (11) and C-6′ of gentamicin X2 
(12), respectively (Figure 1-4). While GenD1 can be expressed in Eschericha coli as a 
soluble protein,16 GenK was isolated as inclusion bodies and must be subjected to a series 
of denaturation and renaturation to make it soluble prior to reconstitution of its [4Fe–4S] 
cluster.17 Both enzymes methylate unactivated sp3 carbons in the presence of SAM, 
reductant, and cobalamin. NADPH together with methyl viologen acting as a redox 
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mediator was found to be a reliable source of reducing equivalents supporting the catalysis 
in vitro. The formation of G-418 (13) by GenK was accompanied by the production of a 
stoichiometric amount of 5′-dAdo (4) and S-adenosylhomocysteine (14, SAH), indicative 
of the consumption of two equivalents of SAM per turnover. After the initial hydrogen 
atom abstraction from C-6′ of gentamicin X2 (12), a methyl radical can be transferred from 
methylcobalamin to the substrate radical to yield the product and cob(II)alamin (Figure 1-
5, pathway A). Methylcobalamin may then be regenerated by reduction and methyl transfer 
from SAM. Alternatively, the formation of a substrate radical followed by deprotonation 
to afford a ketyl radical enables the nucleophilic methyl transfer reaction that generates 
cob(I)alamin (Figure 1-5, pathway B). The resulting alkoxy product radical should be 
reduced. The conversion of gentamicin A to gentamicin X2 by GenD1 also generated 5′-
dAdo, and the reaction mechanism of GenD1 is thought to be similar to that of GenK. 
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Figure 1-5. Proposed mechanism of methylation by GenK. 
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Similarly, a cobalamin-dependent radical SAM methyltransferase Fms7 was 
proposed to catalyze the C-methylation of fortimicin KL1 (15) during the biosynthesis of 
fortimicin A (17), an aminoglycoside antibiotic produced by Micromonospora 
olivasterospora.18 MoeK5 was also implicated as a cobalamin-dependent radical SAM 
methyltransferase involved in the biosynthesis of moenomycin (20) in Streptomyces 
ghanaensis.19 Deletion of the moeK5 gene led to accumulation of the desmethylated 
derivative of moenomycin (18), implying that MoeK5 is required for the introduction of 
methyl group at C4 of the F ring. 
 
 
Figure 1-6. Fms7 and MoeK5 in the biosynthesis of fortimicin A (17) and moenomycin 
(20), respectively. 
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Oxetanocin A (23) produced by Bacillus megaterium is a nucleoside antibiotic with 
an unusual four-membered oxetane ring.20 The biosynthetic gene cluster for oxetanocin is 
encoded on a plasmid and harbors the putative radical SAM enzyme OxsB.21 OxsB 
catalyzes the conversion of deoxyadenosine nucleotide (21) to oxetane aldehyde (22) in 
the presence of SAM, cobalamin, and a reducing system.22 The activity of OxsB also 
requires OxsA, which is a phosphatase encoded in the gene cluster (Figure 1-7). The 
detailed mechanism regarding the roles of cobalamin and OxsA during the ring contraction 
reaction is actively being investigated. 
 
 
Figure 1-7.   Ring contraction reaction catalyzed by OxsB during the biosynthesis of 
oxetanosine A (23). 
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The tunicamycins (30) are fatty acyl nucleoside antibiotics targeting bacterial cell 
wall biosynthesis and eukaryotic N-glycoprotein synthesis.23 Their structures feature a 
unique 11-carbon core, tunicamine, and appended with fatty acyl chains.24 Heterologous 
expression of the putative biosynthetic gene cluster from Streptomyces chartreusis 
identified the minimal gene set essential for the production of tunicamycin, and a likely 
pathway has been proposed based on bioinformatics analysis and gene disruption 
experiments (Figure 1-8).25,26 The key finding in this pathway is the unusual exo-glycal 
intermediates.27 TunA converts UDP-N-acetylglucosamine (24, UDP-GlcNAc) to UDP-6-
deoxy-5,6-ene-GlcNAc (25), and then TunF epimerizes this compound to generate a 
galactose derivative (26, UDP-6-deoxy-5,6-ene-GalNAc). TunB is annotated as a radical 
SAM enzyme, and it is expected to be responsible for the coupling reaction between 26 
and a uridyl moiety (28). The hydrogen abstraction from C-5′ of 28 would lead to radical 
addition to the exo-glycal intermediate (26) to form a stabilized radical intermediate. It was 
observed that the exo-glycal intermediate accumulated in the tunB deletion mutant, 
suggesting the essential role of TunB in the radical-mediated C–C bond formation. TunM 
is predicted to be a radical SAM methyltransferase, although its involvement has not been 
clearly demonstrated. 
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Figure 1-8.   Biosynthesis of tunicamycins (30). 
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Blasticidin S (34)28 and mildiomycin (35),29 produced by Streptomyces 
griseochromogenes and Streptoverticilium rimofaciens, respectively, are representative 
peptidyl nucleosides that inhibit protein synthesis by binding to the large ribosomal subunit 
(Figure 1-9). Given that they share a common cytosyl pyranoside core structure, recent 
bioinformatics studies revealed that several gene products found in their biosynthetic gene 
clusters, which include putative radical SAM enzymes BlsE and MilG, are indeed 
homologous to each other.30 The reconstituted BlsE was shown to catalyze the 
decarboxylation of cytosylglucuronic acid (31, CGA) to produce cytosylarabinopyranose 
(33) in the presence of dithionite or flavodoxin/flavodoxin reductase.31 The disruption of 
milG resulted in the accumulation of 5-hydroxymethyl-CGA (32) implying that the 
formation of 2,3-dideoxy-2,3-ene-pyranose moiety is related to the function of MilG.30 
However, the mechanistic details of those reactions require further characterization. 
 
Figure 1-9.   BlsE-catalyzed decarboxylation in blasticidin S (34) biosynthesis and the 
structure of mildiomycin (35). 
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Avilamycins (36) isolated from Streptomyces viridochromogenes are 
oligosaccharide antibiotics active against Gram-positive bacteria.32 Structurally, 
avilamycins consist of a dichloroisoeverninic acid moiety with a heptasaccharide moiety 
(Figure 1-10). The biosynthetic gene cluster harboring 54 open reading frames was 
identified and contains a putative radical SAM enzyme aviX12.33 The aviX12 inactivated 
mutant produced a new derivative named gavibamycin N1 (37), a modified 
heptasaccharide with a glucose moiety in place of the mannose moiety.34 Thus, AviX12 is 
proposed to catalyze the epimerization reaction during the biosynthesis of avilamycin, a 
reaction necessary to its biological activity. Currently, AviX12 has yet to be characterized 
in vitro so that further investigation will be necessary to establish AviX12 as a radical SAM 
epimerase. 
 
 
Figure 1-10.  Structure of avilamycin A (36) and gavibamycin N1 (37). 
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1.1.3 DesII in the Biosynthesis of Desosamine 
Desosamine (i.e. 3-(dimethylamino)-3,4,6-trideoxyhexose), is an essential 
structural component in many macrolide antibiotics such as erythromycin, methymycin, 
narbomycin, and pikromycin.35 The binding of macrolides to the ribosomal subunit is 
mediated by several hydrogen-bonding interactions which involve the deoxysugar moiety. 
Identification of the biosynthetic gene cluster for desosamine in Streptomyces venezuelae 
revealed the presence of eight open reading frames in the cluster,36 and one of the gene 
products, DesII, has been shown to be a radical SAM enzyme responsible for the C4 
deoxygenation step (Figure 1-11).37 Derived from TDP-D-glucose (38) by DesIV, 
conversion of TDP-4-keto-6-deoxy-D-glucose (39) to the corresponding C4 aminosugar 
(40) is catalyzed by the PLP-dependent aminotransferase DesI. Subsequent removal of the 
amino group at C4 is catalyzed by the radical SAM enzyme DesII.38 Transamination and 
N,N-dimethylation steps are catalyzed by DesV and DesVI, respectively, to generate TDP-
desosamine (43). The following glycosylation to modify the macrolactone ring is mediated 
by DesVII and DesVIII.39 
 
 
 
Figure 1-11.  Biosynthetic pathway of TDP-desosamine (43). 
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Extensive biochemical characterization of DesII reaction strongly implicated the 
involvement of radical chemistry in the formation of C4 deoxy sugar 41.40 Interestingly, 
DesII was found to be capable of catalyzing both the redox neutral deamination of TDP-4-
amino-4,6-dideoxy-D-glucose (40) to yield TDP-3-keto-4,6-dideoxy-D-glucose (41) and 
the oxidative dehydrogenation of TDP-D-quinovose (44) to yield TDP-3-keto-6-deoxy-D-
glucose (45, see Figure 1-12).41 Both reactions consume one equivalent of SAM per TDP 
sugar processed. While the deamination reaction requires an external source of reducing 
equivalents, the dehydrogenation reaction can regenerate the reduced [4Fe–4S]1+ cluster in 
the absence of an external reductant during the catalytic cycle.  
 
 
Figure 1-12.  Dehydrogenation of TDP-D-quinovose (44) by DesII.  
The initial hydrogen abstraction from the substrate occurs at C3. This has been 
confirmed by the observation that the deuterium of TDP-[3-2H]-4-amino-4,6-dideoxy-D-
glucose is incorporated into 5′-deoxyadenosine during catalysis by reconstituted DesII.40 
A radical intermediate that forms during the DesII-catalyzed dehydrogenation of TDP-D-
quinovose has been characterized by EPR spectroscopy.42 The doublet of doublets splitting 
pattern at a g-value of 2.0025 with hyperfine splitting constants of 33.6 G was detected. 
This EPR signal collapsed to a broad doublet when the C4-deuterated isotopologue (i.e., 
TDP-D-[4-2H]-quinovose) was incubated with DesII. Moreover, a reduction of the peak 
widths was observed when the reaction was conducted in D2O instead of H2O. These results 
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were consistent with the formation of an α-hydroxyalkyl radical centered at C3 with 
equivalent hyperfine couplings to the hydrogen atoms at both C2 and C4. The dihedral 
angle between the partially occupied p-orbital at C3 and the C–H bonds at C2 and C4 was 
estimated from coupling constants to be approximately 15°, which is not optimal for the 
elimination of substituents at C2 and C4. The measurement of solvent deuterium kinetic 
isotope effects using EPR spectroscopy and the pH titration of the dehydrogenation 
reaction provided additional mechanistic insights that deprotonation of the α-hydroxyalkyl 
radical takes place either prior to or in concert with electron transfer.43  
Based on the aforementioned experimental evidence, a mechanism for the 
dehydrogenation of TDP-D-quinovose (44) by DesII has been proposed (Figure 1-13). This 
mechanism postulates an active site residue that can serve as a Lewis base and form a 
hydrogen-bonding interaction with the hydroxyl group at C3 of TDP-D-quinovose. Upon 
binding of SAM and the substrate, the reductive cleavage of SAM and hydrogen 
abstraction at C3 result in the generation of the α-hydroxyalkyl radical intermediate (46) 
observed by EPR. Deprotonation of the substrate radical by the active site base generates 
a ketyl radical (47), which may sufficiently lower the redox potential of substrate radical 
so as promote single electron transfer to the [4Fe–4S]2+ cluster.44,45 The electron transfer 
completes the dehydrogenation reaction with regeneration of the [4Fe–4S]1+ cluster. 
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Figure 1-13.  Proposed mechanism of dehydrogenation of TDP-D-quinovose (44) by 
DesII. 
 
Although EPR characterization of a radical intermediate during the deamination 
reaction has not been successful yet, the current hypothesis proposes that the substrate 
radical formed during the deamination reaction adopts an alternative conformation 
compared to TDP-D-quinovose (Figure 1-14). It is proposed that TDP-4-amino-4,6-
dideoxy-D-glucose (40) binds in the active site in such conformation that would allow a 
productive orbital overlap for elimination of amino group at C4. The exact mechanism for 
deamination after the formation of substrate radical (48) remains to be established; 
however, two possible mechanisms have been proposed: 1,2-migration and direct 
elimination. The first hypothesis involves migration of the amino group to C3 resulting in 
a carbinolamine radical intermediate (49), a process analogous to the radical deamination 
reaction catalyzed by B12-dependent ethanolamine ammonia lyase (EAL) (Pathway A).
46,47 
Reduction of the resulting carbinolamine radical and elimination of ammonia generate the 
corresponding C3 ketosugar (41). The alternative hypothesis is a direct elimination 
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mechanism, in which deprotonation of the substrate radical is followed by the direct 
elimination of amino group at C4. However, deprotonation would seem to promote 
dehydrogenation rather than deamination, as is the case with TDP-D-quinovose. This 
conflict can be resolved by catalytic model in which the active site general base does not 
deprotonate the substrate or substrate radical but rather serves to facilitate a proton transfer. 
In this case, proton transfer from the C3 hydroxyl group to the C4 amino group proceeds 
in concert with the elimination of ammonia (Pathway B, 50). A computational study of 
EAL-catalyzed transformation also suggests that the energy barrier for direct loss of an 
ammonium cation is comparable to that for migration of a protonated amine group.47 
Regardless of which mechanism is operating, the deamination reaction requires an external 
electron source to reduce the product radical and regenerate the [4Fe–4S]1+ cluster during 
each catalytic cycle. 
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Figure 1-14.  Proposed mechanism of deamination of TDP-4-amino-4,6-dideoxy-D-
glucose (40) by DesII. 
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1.2 BIOSYNTHESIS OF C-NUCLEOSIDES 
 
1.2.1 C-Nucleosides 
Many fundamental biological activities such as the storage of genetic information, 
control of signaling pathways, and transfer of intracellular energy are mediated by 
nucleosides and nucleotides. A number of modified nucleosides from secondary 
metabolites exhibit a variety of biological properties including antibacterial, antiviral, and 
antitumor activities.48,49 Among them, C-nucleosides in which the nucleobase is attached 
to a sugar moiety via C-glycosidic bond have garnered specific attention due to their 
therapeutic potential.50 Therefore, studies of the biosynthetic pathways of these nucleosides 
and enzyme mechanisms involved in their formation are of interest. 
Many C-nucleosides have been identified. For example, 8-aza-9-deazaadenosine 
(51), commonly known as formycin A, is an antibiotic isolated from Nocardia interforma 
and Streptomyces kaniharaensis SF-557 (see Figure 1-15).51,52 Formycin A is a structural 
isomer of adenosine (53) having a unique pyrazolopyrimidine nucleobase linked to ribose 
via a C-glycosidic bond in contrast to adenosine where an imidazolopyrimidine nucleobase 
is linked to ribose via an N-glycosidic bond. In a similar way, formycin B (52) is the 
corresponding C-nucleoside analog of inosine (54).53 
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Figure 1-15: Structures of formycin A (51), formycin B (52), adenosine (53), and inosine 
(54).  
 
There are several related C-nucleoside antibiotics, which include pyrazomycin 
(55), showdomycin (56), minimycin (57) and pseudouridine (58) (see Figure 1-16). 
Pyrazomycin (or pyrazofurin, 55), produced by Streptomyces candidus, is a pyrazole 
nucleoside that exhibits antiviral and antitumor activities.54 Showdomycin (56) isolated 
from Streptomyces showdoensis55 and minimycin (or oxazinomycin, 57) isolated from 
Streptomyces hygroscopicus56 contain a maleimide ring and an oxazinedione ring, 
respectively. Pseudouridine (58) is a post-transcriptionally modified derivative of uridine 
found in RNA.57 The uracil moiety in pseudouridine is also attached to the ribose moiety 
via a C-glycosidic bond. 
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Figure 1-16: Structures of representative C-nucleosides: pyrazomycin (55), showdomycin 
(56), minimycin (57) and pseudouridine (58). 
 
1.2.2 Biosynthesis of Pseudouridine 
While the biogenesis of C-nucleosides in nature remains an active area of 
investigation, pseudouridine (58) represents one example where the biosynthetic pathway 
has been established. Pseudouridine is derived from uridine in RNA (59) upon 
isomerization by pseudouridine synthase as shown in Figure 1-17.58 The proposed 
mechanism involves an essential aspartate residue that operates as a general base.59 
Elimination of the uracil moiety may be either stepwise followed by the deprotonation of 
oxocarbenium intermediate (Pathway A), or concerted with deprotonation at C2′ (Pathway 
B), which generates the key glycal intermediate 60. The pyrimidine ring can then rotate in 
the active site prior to addition back to the ribose to form the C-glycoside. 
 23 
 
 
Figure 1-17: Mechanistic proposals for the biosynthesis of pseudouridine (58) from 
uridine.  
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Ezomycins produced by a Streptomyces species are bicyclic uronic acid nucleosides 
that exhibit antifungal activity.60 Whereas ezomycin A1 (62) and A2 (63) are cytosine N-
nucleosides that share the octosyl acid core scaffold, ezomycin B1 (64) and B2 (65) are C-
nucleosides containing a pseudouridine moiety instead of cytosine (Figure 1-18).61,62 
Structurally related, malayamycin A (66) isolated from Streptomyces malaysiensis is a 
bicyclic C-nucleoside with strong antifungal activity.63 Biosynthesis of the octosyl acid 
core scaffold (73) was proposed to be derived from phosphoenolpyruvate (70, PEP) and a 
uridine derivative based on the isotope labeling studies.64 In vitro characterization of the 
radical SAM enzyme PolH and the phosphatase PolJ provided evidence for a biosynthetic 
pathway of octosyl acid that begins with uridine 5′-monophosphate (69, UMP, see Figure 
1-19).65 As of yet, no biosynthetic studies have been conducted to elucidate the 
biotransformations leading to the ezomycins or malayamycin A. However, it is conceivable 
that an isomerase similar to pseudouridine synthase may operate to construct the C-
glycosidic linkage, given the fact that both C-nucleosides and the structurally analogous 
N-nucleosides have been isolated together from the same culture filtrates. 
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Figure 1-18. Structures of ezomycins (62, 63, 64, 65), malayamycin A (66) and octosyl 
acids (67, 68). 
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Figure 1-19. Proposed pathway for the octosyl acid core scaffold (73). 
 
 
1.2.3 Biosynthesis of Formycin A and Related C-Nucleosides 
The biosynthetic pathway leading to the formation of the C-glycosidic bond found 
in the formycins (51, 52), pyrazomycin (55), showdomycin (56), and minimycin (57) 
remains elusive. Early studies of formycin A biosynthesis have identified a sequence of 
chemical transformation from formycin B 5′-phosphate (77) to formycin A (51) via 
formycin A 5′-phosphate (78) that are proposed to take place in vivo (see Figure 1-20).66 
Isotope tracing experiments in N. interforma have shown that the ribosyl moiety of 
formycin A is derived directly from ribose likely via an intermediary produced from 
phosphoribosyl pyrophosphate (74, PRPP).67 The ε-amino group of L-lysine (76) was found 
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to be the source of the N3, N7, and N8 nitrogen centers of formycin A.68,69 Importantly, 
the C6, C5, C4, and C9 carbons of formycin A originate from the C1, C2, C3, and C4 
carbons of L-glutamate (75), implying that L-glutamate is asymmetrically incorporated into 
formycin A as an intact precursor (Figure 1-20).69,70 The biosynthetic origins of formycin 
A differ from those for adenosine (53) where the C4, C5 and N7 centers are from L-glycine 
(79, see Figure 1-21).71 The other two nitrogens on the adenine ring of 53, namely N3 and 
N9, are derived from L-glutamine (80), while bicarbonate is the source of the C6 carbon, 
and the C2 and C8 centers originate from N10-formyl-tetrahydrofolate (N10-formyl-THF). 
Thus, the biosynthetic pathway for formycin A (51) appears to be distinct from that of 
adenosine (53) despite their significant structural resemblance. 
 
 
 
Figure 1-20. Biosynthetic origins of formycin A (51). 
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Figure 1-21. Biosynthetic origins of adenosine (53). 
 
 
L-glutamate (75) appears to be a common precursor for the formycin class of 
nucleoside antibiotics, given similar isotope incorporation patterns. The four adjacent 
carbons of formycin A are directly derived from C1 to C4 of L-glutamate as are all of the 
carbons of the pyrazole ring and amide carbon of pyrazomycin (55).70 Furthermore, the 
precursor of the maleimide ring in showdomycin (56) and that of the oxazinedione ring in 
minimycin (57) have also been shown to be L-glutamate by feeding experiments. The 
maleimide moiety of showdomycin is constructed from the C2 to C5 four-carbon unit and 
nitrogen from L-glutamate.72 Likewise, the three carbons from C3 to C5 of L-glutamate are 
asymmetrically incorporated into C6 to C4 of the oxazine ring of minimycin.73 A common 
intermediate for C-nucleosides is thus hypothesized and believed to be formed via coupling 
of PRPP (74) and L-glutamate (75) followed by the loss of either the C1 or C5 carbon of 
L-glutamate upon decarboxylation. 
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The biosynthesis of C-nucleosides seems to be different from that of other naturally 
occurring aryl C-glycosides where the sugar moiety is attached to the aromatic ring by a 
C-C bond.74 Although the mechanistic features of enzymatic C-glycosyl transfers are not 
completely understood in comparison to those of O-glycosyltransfers,75 several C-
glycosyltransferases have been reported and characterized,76-78 which include IroB from E. 
coli. IroB catalyzes three consecutive glucosyl transfers from uridine 5′-diphosphoglucose 
(82, UDP-Glc) to enterobactin (81, see Figure 1-22).79 The C-glycosylation by IroB has 
been proposed to proceed via a Friedel-Crafts like reaction mechanism as shown in Figure 
1-23.80 The C-C bond is formed via nucleophilic attack to the anomeric carbon of an NDP-
sugar donor and is facilitated by electron-donating groups on the aromatic ring. A study of 
the catalytic promiscuity of C-glycosyltransferase indicated that the regiospecificity of C-
glycosylation is determined by the chemical properties and the locations of substituents on 
the aromatic ring.81 The positioning of the sugar acceptor by active site residues also plays 
a significant role.82,83 In contrast, the assembly of C-nucleosides is less likely to follow the 
aromatic substitution mechanism, because their heterocyclic nucleobases lack electron-
donating substituents as directing groups. 
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Figure 1-22. IroB-catalyzed glucosylations of enterobactin (81). 
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Figure 1-23. Proposed mechanism of C-glycosylation in the biosynthesis of C-glycosides. 
 
 
1.3 SUMMARY AND THESIS STATEMENT 
The radical SAM enzyme DesII can operate either as a lyase or a dehydrogenase 
depending on the substrate provided. The dual functionality of DesII raises the question of 
how the fate of the radical intermediate is governed during the catalytic cycle. It is 
hypothesized that substrate geometry in the active site plays an important role in controlling 
the partitioning of the radical intermediate into different reaction pathways. Specifically, 
the mechanistic difference between deamination and dehydrogenation reactions may be 
caused in large part by the degree of orbital overlap in the bound radical intermediate. In 
Chapter 2, mechanistic investigation of DesII reactions with several substrate analogs is 
described. It was shown that all analogs with altered stereochemistry can be processed by 
DesII, despite being poor substrates. Characterization of each product demonstrated that 
the reaction partitions into alternative pathways upon changing the stereochemistry of the 
ring substituents of the substrate. This study provides experimental evidence that the 
stereochemical configuration of the substrate radical significantly contributes to the 
reaction outcomes during the catalytic cycle of DesII. 
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Formycin A, isolated from N. interforma and S. kaniharaensis, is a C-nucleoside 
analog of adenosine. The biosynthesis of nucleosides is of particular interest because of 
their unique structural features such as the pyrazolopyrimidine moiety with a C-glycosidic 
linkage in formycin A. Chapter 3 focuses on the identification and characterization of the 
biosynthetic gene cluster for formycin A. In order to investigate the biosynthesis of 
formycin A, the genome of S. kaniharaensis was sequenced. Further analysis led to a 
plausible route for the assembly of the pyrazolopyrimidine moiety in formycin A. The 
biosynthetic gene cluster was later identified by construction and screening of a cosmid 
library. Bioinformatics analysis permitted assignment of putative functions of each gene, 
from which a biosynthetic pathway for formycin A could be proposed. Several of the 
enzymes involved in the biosynthesis of formycin A have been cloned, expressed, and 
assayed for activity. The ultimate goal of this research is to fully elucidate the entire 
biosynthetic pathway of formycin A, and investigate the detailed reaction mechanisms of 
the enzymes involved. 
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Chapter 2:  Mechanistic Investigation of the Radical SAM Enzyme 
DesII Using Substrate Analogs with Altered Stereochemistry  
 
2.1 INTRODUCTION 
DesII is the radical SAM enzyme from S. venezuelae that catalyzes the deamination 
of TDP-4-amino-4,6-dideoxy-D-glucose (40) to produce TDP-4,6-dideoxy-3-keto-D-
glucose (41) (see Figure 2-1).40 The deamination is the key reaction in the biosynthesis of 
TDP-desosamine (43), which is an indispensable structural component required for the 
biological activity of many macrolide antibiotics.35 The radical-mediated deamination 
reaction catalyzed by DesII represents one of the regioselective deoxygenation reactions 
of a glucose derivative to achieve structural diversity. However, when DesII is presented 
with the nonbiosynthetic substrate TDP-D-quinovose (44), in which the C4 amino group is 
replaced by a hydroxyl group, it catalyzes oxidation of the C3 hydroxyl group to generate 
TDP-3-keto-6-deoxy-D-glucose (45).41 The oxidative dehydrogenation of 44 is analogous 
to the oxidation of 2-deoxy-scyllo-inosamine (7) catalyzed by the radical SAM enzyme 
BtrN in the biosynthesis of butirosin (see Figure 1-2 in Chapter 1.1.2),9 which is in stark 
contrast with the redox-neutral deamination of 40. Moreover, it is unexpected that DesII 
does not catalyze the dehydration of 44 given the precedence set by the dehydration of 1,2-
diols by cobalamin-dependent dioldehydratases.84 Furthermore, given the fact that 
nonenzymatic dehydration of α,β-dihydroxyalkyl radicals was observed in solution also 
suggests that the dehydration of radical adducts of 44 should be rapid.85-87 Therefore, study 
                                                 
 The part of this chapter has been published, and I was the primary author (Ko, Y.; Ruszczycky, M. W.; 
Choi, S.-H.; Liu, H.-w. Mechanistic studies of the radical S-adenosylmethionine enzyme DesII with TDP-
D-fucose. Angew. Chem. Int. Ed. 2015, 54, 860–863). 
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of the mechanistic details underlying the dual activity of DesII may shed light on the 
subtleties of radical control during the catalytic cycle.   
 
 
 
Figure 2-1. Reactions catalyzed by DesII. 
 
The radical intermediate formed during the dehydrogenation of 44 was identified 
by EPR spectroscopy to be an α-hydroxyalkyl radical centered at C3 (46, see Figure 1-
13).42 The C–O bonds at both C2 and C4 are essentially orthogonal to the partially filled 
p-orbital at C3, which should impede elimination of the hydroxyl groups. On the contrary, 
a different binding configuration of the substrate radical from 40 is proposed in which the 
C4 amino group is better overlapped with the p-orbital at C3 allowing the deamination 
reaction to take place.88 It is hypothesized that the degree of orbital interaction, which 
depends on the binding configuration of the parent compound in the active site, plays a key 
role in determining whether the enzyme operates as a lyase or a dehydrogenase (see the 
discussion in Chapter 1.3). When sufficient hyperconjugation between the C4 substituent 
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and the C3 p-orbital is provided, the elimination reaction can occur to afford 
deamination/dehydration products. If the binding configuration does not allow a productive 
orbital overlap so that elimination is impeded, competing processes such as deprotonation 
of the C3 hydroxyl group by an active site base may become significant.43 In this case, the 
electron transfer to the [4Fe–4S]2+ cluster would be facilitated by the more strongly 
reducing ketyl radical (47) and the reaction should then proceed with elimination of the C4 
substituent. 
This working hypothesis implies that perturbation of the hyperconjugation between 
the singly occupied p-orbital at C3 and the C4 C–N/O bond of the radical intermediate can 
modulate partitioning between the elimination and oxidation pathways.88 In order to 
investigate this hypothesis, the reaction of DesII with several diastereomeric substrate 
analogs were examined and the results are described in this chapter. The substrate analogs 
employed in this study include TDP-4-amino-4-deoxy-D-fucose (85), TDP-D-fucose (86), 
and TDP-6-deoxy-D-mannose (87, see Figure 2-2). Compounds 85 and 86 represent the C4 
epimers of TDP-4-amino-4,6-dideoxy-D-glucose (40) and TDP-D-quinovose (44), 
respectively, and their reactions with DesII could provide mechanistic insight regarding 
the influence of the stereochemistry at C4. Furthermore, the fate of 87 is of interest, because 
the inverted configuration at C2 may facilitate elimination of the C2 substituent. Reported 
herein is the experimental evaluation of the DesII reaction with 85, 86, and 87. The study 
using 86 as a potential substrate has been published, and the results and discussion are 
directly adapted from that publication.89    
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Figure 2-2. Structures of substrate analogs employed in this study. 
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2.2 EXPERIMENTAL PROCEDURES 
 
2.2.1 General 
All reactions involving DesII were performed in a Coy anaerobic chamber 
(glovebox) under an atmosphere of approximately 97.5% N2 and 2.5% H2 with less than 1 
ppm O2. All chemicals were obtained from commercial sources and used without further 
purification unless specified otherwise. Except for those prepared with D2O (see Chapter 
2.2.4.2), all solvents were deaerated by bubbling with nitrogen gas before being transferred 
into the glovebox. Once in the glovebox, the solvents were stirred open to the anaerobic 
atmosphere overnight to allow equilibration. All electrospray ionization mass spectrometry 
(ESI-MS) was performed at the Mass Spectrometry Facility of the University of Texas at 
Austin using an Agilent 6530 Q-TOF MS. All NMR spectroscopy was performed at the 
NMR Facility of the University of Texas at Austin. 
 
2.2.2 Enzymes 
2.2.2.1 DesII 
DesII from S. venezuelae containing a C-terminal His6 tag was heterologously 
overexpressed in BL21 Star E. coli using a pET24b(+) expression plasmid and purified 
aerobically according to previously published methods.40 The purified enzyme in 50 mM 
potassium phosphate buffer (pH 7.5) containing 15% glycerol was flash frozen and stored 
at –80 °C in approximately 0.5 mL aliquots containing roughly 2.5 mg protein each. 
Reconstitution also followed previously published methods.41,42 Prior to 
reconstitution, approximately 3–5 mg of enzyme was thawed and dialyzed overnight versus 
25 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid (EPPS) buffer (pH 8.0) 
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containing 10% glycerol under a N2 atmosphere at 4 °C. The dialysis system was then 
transferred to the glovebox. There, the dialyzed enzyme was diluted to a volume of ca. 2 
mL and gently stirred at ca. 10 °C in an open conical vial in order to equilibrate with the 
anaerobic atmosphere. The solution was then made 5 mM in dithiothreitol (DTT) and 
allowed to stir for 15 min before adding SAM to 1.5 mM and allowing the reaction to stir 
for another 5 min. Next, 100 μL of a 40 mM solution of Fe(NH4)2(SO4)2 in anaerobic H2O 
was slowly added over 10 min. This was followed by the slow addition of 100 μL of a 40 
mM solution of Na2S in anaerobic 25 mM EPPS buffer (pH 8.0) over 20 min. Once all of 
the Na2S had been added, the solution was gently stirred at ca. 10 °C for 5 h. The 
reconstituted enzyme was then loaded onto a 50 mL Sephadex G-25 column prequilibrated 
with anaerobic buffer containing 25 mM EPPS (pH 8.0) and 1 mM DTT, and the column 
was eluted with the same buffer. Brown colored fractions were collected, pooled, 
concentrated to approximately 30 μM enzyme and stored in the glovebox at ca. 10 °C until 
use. 
2.2.2.2 FdtA 
The ketoisomerase FdtA containing an N-terminal His6 tag was heterologously 
overexpressed and purified as previously described.90 The fdtA gene from Aneurinibacillus 
thermoaerophilus was PCR amplified and cloned into the pET28b(+) vector at the NdeI 
and EcoRI restriction sites. The primers used were: 5′-GGGTAGGGCATATGGAAAA-
TAAAG-3′ (forward, with the NdeI site underlined) and 5′-CCCGAATTCTTATCCTTC-
TTTTTC-3′ (reverse, with the EcoRI site underlined). The resulting plasmid was used to 
transform E. coli BL21 Star (DE3) cells. 
An overnight culture of E. coli transformed with the fdtA/pET28b(+) plasmid was 
then grown at 37 °C in LB medium containing 50 μg/mL kanamycin and used to inoculate 
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six 1 L of the same medium in a 100-fold dilution. The 1 L cultures were incubated at 37 
°C until the OD600 reached 0.6, at which point protein expression was induced by the 
addition of isopropylthiogalactoside (IPTG) to a final concentration of 0.2 mM, and the 
temperature was decreased to 18 °C. Following overnight incubation at 18 °C, the cells 
were harvested by centrifugation at 4500 × g for 8 min, resuspended in 80 mL of 100 mM 
Tris buffer (pH 8.0) containing 300 mM NaCl and disrupted by sonication. Cell debris was 
removed by centrifugation at 20000 × g for 30 min, and the supernatant was mixed with 8 
mL of nickel-nitrilotriacetic acid (Ni-NTA) resin for 10 min under slow agitation at 4 °C. 
The slurry was transferred to an empty column and washed with 100 mL of 100 mM Tris 
buffer (pH 8.0) containing 300 mM NaCl and 20 mM imidazole. The protein was eluted 
with 50 mL of 100 mM Tris buffer (pH 8.0) containing 300 mM NaCl and 250 mM 
imidazole and dialyzed twice against 1 L of 100 mM Tris buffer (pH 8.0) containing 300 
mM NaCl and 20% glycerol. The dialyzed protein was then flash frozen with liquid N2 and 
stored at –80 °C until use. 
2.2.2.3 RfbB, DesV, and Tyl1a 
The TDP-glucose 4,6-dehydratase RfbB from Salmonella typhi,91 the transaminase 
DesV from S. venezuelae,36 and the 3,4-ketoisomerase Tyl1a from Streptomyces fradiae92 
were overexpressed and purified as previously described. 
 
2.2.3 Compounds 
2.2.3.1 SAM and [5′,5′-2H2]SAM  
SAM was prepared from adenosine triphosphate (ATP) and L-methionine using the 
SAM synthetase MetK and isolated using cation exchange batch phase extraction as 
previously described with minor variations.93,94 The dideuterated isotopolog S-[5′,5′-
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2H2]adenosyl-L-methionine ([5′,5′-2H2]SAM) was prepared analogously to natural 
abundance SAM using [5′,5′-2H2]adenosine triphosphate ([5′,5′-2H2]ATP) and L-
methionine. The HRMS (ESI, positive ion mode) calculated for the product 
C15H21D2N6O5S
+ [M]+ was 401.1569 m/z, versus the observed 401.21 m/z. [5′,5′-2H2]ATP 
was synthesized from adenosine (53) according to previously described procedures by Dr. 
Sei Hyun Choi.95 
2.2.3.2 DesII substrate analogs: TDP-4-amino-4-deoxy-D-fucose, TDP-D-fucose, and 
TDP-6-deoxy-D-mannose 
The deuterated substrate analogs, TDP-[3-2H]-4-amino-4-deoxy-D-fucose (85D) 
and TDP-[3-2H]-6-deoxy-D-mannose (87D) were chemically synthesized by Geng-Min 
Lin (manuscript in preparation). TDP-D-fucose (86) was prepared and purified as 
previously described (see Figure 2-3).40 
2.2.3.3 TDP-6-deoxy-D-gulose  
TDP-6-deoxy-D-gulose standard (98) was prepared from TDP-D-glucose (38) as 
shown in Figure 2-3. A 10 mL solution containing 30 mM TDP-D-glucose (38), 0.3 mM 
NAD, 50 mM Tris (pH 7.5), and ca. 1 mg RfbB was incubated at 37 °C for 5 h. Next, ca. 
3 mg FdtA was added to the reaction mixture, and the solution was incubated at room 
temperature overnight. After centrifugation and filtration using a Millipore YM-10 
ultrafiltration membrane, 20 mM NaBH4 was added and the reaction mixture was incubated 
for 1 h on ice. The FdtA reaction equilibrium favors TDP-6-deoxy-4-keto-D-glucose (39); 
therefore, reduction by NaBH4 generated a mixture of TDP-D-quinovose (44), TDP-D-
fucose (86) and TDP-6-deoxy-D-gulose (98). The desired product (98) was purified by 
HPLC using a Dionex CarboPac PA1 semiprep column. A two-solvent system of A, H2O, 
and B, 1.5 M ammonium acetate in H2O (pH 7.0), was used with a flow rate of 3 mL/min. 
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The column was eluted with a two-phase linear gradient: 2.5 to 15% B in 20 min, 15 to 
20% B in 20 min and return to 2.5% B in 5 min. Although TDP-D-fucose (86) could be 
removed in this manner, complete separation of TDP-D-quinovose (44) from TDP-6-
deoxy-D-gulose (98) was not possible, because the elution times were very similar at ca. 
25.5 min. Nevertheless, two consecutive HPLC purifications produced a 2:1 mixture of 
TDP-6-deoxy-D-gulose to TDP-D-quinovose. NMR characterization of the TDP-D-
quinovose was consistent with previous reports permitting deconvolution of spectroscopic 
data for TDP-6-deoxy-D-gulose.96 1H NMR and 31P NMR spectra are shown in Figure 2-4 
and Figure 2-5, respectively. 1H NMR (D2O, 600 MHz) δ (ppm) 7.58 (s, 1H, 6-H), 6.19 
(dd, 1H, J = 7.0, 7.0 Hz, 1′-H), 5.38 (dd, 1H, J = 3.7, 6.8 Hz, 1′′-H), 4.45–4.49 (m, 
convoluted with HOD peak, 1H, 3′-H), 4.29 (q, 1H, J = 6.6 Hz, 5′′-H), 4.00–4.06 (m, 3H, 
4′-H, 5′-H), 3.82 (dd, 1H, J = 3.7, 3.7 Hz, 3′′-H), 3.76 (ddd, 1H, J = 3.7, 3.7, 3.7 Hz, 2′′-
H), 3.59 (d, 1H, J = 3.7 Hz, 4′′-H), 2.18–2.26 (m, 2H, 2′-H), 1.77 (s, 3H, CH3), 1.07 (d, 
3H, J = 6.6 Hz, 6′′-H); 31P NMR (D2O, 243 MHz) δ (ppm) –11.31 (d, J = 20.0 Hz), –13.03 
(d, J = 20.0 Hz). HRMS (ESI, negative ion mode) calculated for C16H25O15N2P2
– [M – H]–
: 547.0736 m/z, found: 547.0723 m/z.  
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Figure 2-3.   Preparation of TDP-6-deoxy-D-gulose (98) and TDP-3-amino-3-deoxy-D-
fucose (101). 
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Figure 2-4.   1H NMR of TDP-6-deoxy-D-gulose (98).  
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Figure 2-5.   31P NMR of TDP-6-deoxy-D-gulose (98). 
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2.2.3.4 TDP-3-amino-3-deoxy-D-fucose 
A 5 mL solution containing 30 mM TDP-D-glucose (38), 0.3 mM NAD, 50 mM 
Tris (pH 7.5), and approximately 0.5 mg RfbB was incubated at 37 °C for 5 h. The reaction 
mixture was made 10 mM in L-glutamate, 0.8 mM in PLP and approximately 0.3 mg FdtA 
and 1.5 mg DesV were added. After incubation at 37 °C for 4 h, the reaction mixture was 
filtered using a Millipore YM-10 ultrafiltration membrane and lyophilized. The product 
TDP-3-amino-3-deoxy-D-fucose (101) was purified by semiprep HPLC in the same 
manner as 98, and 101 typically elutes at approximately 6 min. The collected compound 
was lyophilized to dryness and characterized by ESI-MS and NMR spectroscopy. The 
observed 1H NMR spectra are consistent with the reported values.90 HRMS (ESI, negative 
ion mode) calculated for C16H26N3O14P2
– [M – H]–: 546.0895 m/z, found: 546.0882 m/z. 
2.2.3.5 Dihydropyran standards 
The (2R,3R)-2-methyl-3,5-dihydroxy-4-keto-2,3-dihydropyran standard (105) was 
prepared according to a previously described procedure (Figure 2-6).92 A 3 mL solution 
containing 5 mM TDP-D-glucose (38), 0.3 mM NAD, 10 mM magnesium chloride, 50 mM 
photassium phosphate (pH 7.5), and 0.5 mg RfbB and 0.1 mg Tyl1a was incubated at 37 
°C for 5 h. Then the reaction mixture was filtrated using a Millipore YM-10 ultrafiltration 
membrane and the filtrate was lyophilized. The product was purified by HPLC in the same 
manner as 101, and the desired product typically elutes at approximately 2 min, which is 
consistent with previous report. The collected compound was lyophilized to dryness and 
characterized by ESI-MS. HRMS (ESI, positive ion mode) calculated for C6H9O4
+ [M + 
H]+: 145.0495 m/z, observed: 145.0494 m/z. The (2R,3R)-2-methyl-3-hydroxy-4-keto-2,3-
dihydropyran standard (106) was chemically synthesized by Geng-Min Lin (manuscript in 
preparation).  
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Figure 2-6.   Preparation of (2R,3R)-2-methyl-3,5-dihydroxy-4-keto-2,3-dihydropyran 
(105). 
 
2.2.4 DesII and DesII/DesV Assays 
A typical reaction of DesII was conducted by incubating 0.25–1 mM substrate and 
0.5–1 mM SAM with 10–20 μM DesII in an anaerobic buffer containing 25 mM EPPS (pH 
8.0), 1 mM DTT and 0.5–1 mM Na2S2O4 at room temperature or at 30 °C. When the 
incubation was longer than 2 h, additional Na2S2O4 was added every 2 h to compensate for 
its decomposition. Reaction aliquots of 50 or 100 μL were taken at appropriate times and 
deproteinized using YM-10 centrifugal filters. The filtrate of each sample was then frozen 
and stored at –80 °C until analyzed by HPLC. An analytical 4 × 25 mm Dionex CarboPac 
PA1 anion exchange HPLC column was employed using a two-solvent system: solvent A 
was H2O, and solvent B was 1.5 M ammonium acetate in H2O (pH 7.0). The flow rate was 
1 mL/min and the UV-absorbance detector was set to 267 nm. The column was eluted with 
a two-phase linear gradient: 2.5 to 15% B in 20 min, 15 to 20% B in 20 min and then return 
to 2.5% B in 5 min. For the coupled DesII and DesV assay, 10 mM L-glutamate, 0.8 mM 
PLP and 10 μM DesV were included in the reaction mixture. Work up and analysis of 
reactions that included the DesV assay components were the same as those described above 
for DesII alone. 
Reduction with NaBH4 was used to trap the TDP-sugar product(s) containing the 
3-keto functional group. NaBH4 was added to the reaction aliquots taken at given time 
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points to a final concentration of 100 mM. After additional incubation on ice for 1 h, the 
reaction mixture was analyzed by HPLC as described above. In some cases, 5 mM NaBH4 
was included in the reaction mixture at the beginning of the reaction, and the reaction 
mixture was analyzed by HPLC at given time points. The enzyme activity in the presence 
or absence of 5 mM NaBH4 was found to be the same. 
The formation of dihydropyrans such as 105 and 106 in the DesII reaction with 
TDP-[3-2H]-6-deoxy-D-mannose (87D) was analyzed by employing an analytical 250 × 
4.6 mm Agilent Microsorb 100-5 C18 HPLC column in a two-solvent system of A, 1% 
ammonium acetate (pH 5.1), and B, acetonitrile. The samples were eluted with 2% B for 5 
min, 2 to 10% B for 18 min, 10 to 35% B for 9 min, and then return to 2% B for 2 min. 
The flow rate was 1 mL/min and the detector was set to 267 nm.  
 
2.2.5 1H NMR Characterization of Species Y 
Three preparatory 5 mL reaction mixtures containing 0.25–0.5 mM SAM, 0.12–
0.250 mM 86, 0.5 mM Na2S2O4, and 10–15 μM DesII in 25 mM EPPS (pH 8.0) were 
incubated anaerobically at room temperature for 8 h, and additional Na2S2O4 was added 
every 2 h. The reaction mixture was deproteinized using a Millipore YM-10 ultrafiltration 
membrane and lyophilized. The product Y was isolated using a Dionex CarboPac PA1 
semiprep column with a flow rate of 3 mL/min. The column was eluted using a two solvent 
system of A, H2O, and B, 1 M ammonium bicarbonate in H2O, with the following gradient: 
3.75 to 30% B in 40 min, followed by a return to 3.75% B in 5 min. The collected product 
was lyophilized to dryness prior to analysis by ESI-MS and 1-D as well as 2-D 1H NMR 
spectroscopy. Two contaminating species were also observed in the NMR spectra in 
addition to TDP-6-deoxy-D-gulose: a 1,2-cyclic sugar phosphate and thymidine 
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monophosphate (TMP). 1H NMR and 31P NMR spectra are shown in Figure 2-7 and Figure 
2-8, respectively. 
Species Y: 1H NMR (D2O, 600 MHz) δ (ppm) 7.60 (s, 1H, 6-H), 6.19–6.24 (m, 1H, 
1′-H, convoluted with 1′-H of TMP), 5.41 (dd, 1H, J = 3.7, 7.2 Hz, 1′′-H), 4.46–4.51 (m, 
convoluted with HOD peak, 1H, 3′-H), 4.29–4.34 (m, 1H, 5′′-H), 4.05 (d, 3H, J = 4.4 Hz, 
4′-H, 5′-H), 3.84 (dd, 1H, J = 3.7, 3.7 Hz, 3′′-H), 3.78 (ddd, 1H, J = 3.7, 3.7, 3.7 Hz, 2′′-
H), 3.62 (d, 1H, J = 3.7 Hz, 4′′-H), 2.18–2.31 (m, 2H, 2′-H, convoluted with 2′-H of TMP), 
1.80 (s, 3H, CH3, convoluted with CH3 of TMP), 1.09 (d, 3H, J = 6.0 Hz, 6′′-H); 31P NMR 
(D2O, 243 MHz) δ (ppm) –11.3 (d, J = 23 Hz), –13.0 (d, J = 20 Hz). HRMS (ESI, negative 
ion mode) calculated for C16H25O15N2P2
– [M – H]–: 547.0736 m/z, found: 547.0729 m/z. 
Contaminant 1,2-cyclic sugar-phosphate: 1H NMR (D2O, 600 MHz) δ (ppm) 5.59 
(dd, 1H, J = 5.2, 15.8 Hz, 1-H), 4.60 (dd, 1H, J = 2.9, 5.2 Hz, 2-H), 4.29–4.34 (m, 1H, 5-
H), 3.69 (dd, 1H, J = 4.7, 6.6 Hz, 4-H), 3.64–3.68 (m, 1H, 3-H), 1.10 (d, 3H, J = 6.0 Hz, 
6-H); 31P NMR (D2O, 243 MHz) δ (ppm) 16.18 (s). HRMS (ESI, negative ion mode) 
calculated for C6H10O7P
– [M – H]–: 225.0170 m/z, found: 225.0175 m/z. 
Contaminant TMP: 1H NMR (D2O, 600 MHz) δ (ppm) 7.67 (s, 1H, 6-H), 6.19–6.24 
(m, 1H, 1′-H, convoluted with 1′-H of Y), 4.42–4.47 (m, convoluted with HOD peak, 1H, 
3′-H), 3.98–4.02 (m, 1H, J = 3.7 Hz, 4′-H), 3.81 (dd, 2H, J = 3.7, 3.7 Hz, 5′-H), 2.18–2.31 
(m, 2H, 2′-H, convoluted with 2′-H of Y), 1.80 (s, 3H, CH3, convoluted with CH3 of Y); 
31P NMR (D2O, 243 MHz) δ (ppm) 3.63 (s). HRMS (ESI, negative ion mode) calculated 
for C10H14O8N2P
– [M – H]–: 321.0493 m/z, found: 321.0496 m/z. 
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Figure 2-7.   1H NMR of Y.  
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Figure 2-8.   31P NMR of Y.  
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2.2.6 Deuterium Incorporation Experiment with TDP-D-fucose 
Anaerobic D2O was prepared via three freeze-thaw cycles using an anaerobic 
Schlenk line supplied with an argon atmosphere. Buffer containing 25 mM EPPS (pH 8.0) 
was prepared in H2O, dried under vacuum, reconstituted with D2O, dried again under 
vacuum and transferred to the anaerobic glovebox where it was reconstituted with the 
anaerobic D2O. Freshly reconstituted DesII was exchanged with the anaerobic EPPS buffer 
in D2O via repeated cycles of concentration using YM-10 centrifugal filters followed by 
addition of D2O buffer. Reactions were run by incubating approximately 10 μM DesII in 
the D2O EPPS buffer with 0.5 mM SAM, 0.25 mM TDP-D-fucose (86) and 0.5 mM 
Na2S2O4 for 2.5–4 h. The reaction mixture was deproteinized using YM-10 centrifugal 
filters and the residual TDP-D-fucose (86) and newly formed TDP-6-deoxy-D-gulose (98) 
in the filtrate were isolated by analytical HPLC as described above. The collected samples 
were lyophilized to dryness and analyzed by ESI-MS. 
The C3-radical intermediate of TDP-D-fucose (i.e., 97 with concentration [97]) is 
treated as decomposing in different ways, each governed by a pseudo-first order rate 
constant under the experimental conditions (see Figure 2-19). Intermediate 97 can partition 
to regenerate TDP-D-fucose (86 with concentration [86]) in two ways: either the reverse of 
97 formation, or net H-atom transfer to the re-face of 97 (governed by kre). In D2O 
containing buffers, TDP-D-[3-2H]fucose (86D with concentration [86D]) will also be 
formed, but only via the latter pathway with net D-atom transfer to 97. In contrast TDP-6-
deoxy-D-gulose (98 with concentration [98]) is only formed via net H-atom transfer to the 
si-face of 97 (governed by ksi). Likewise, TDP-6-deoxy-D-[3-
2H]gulose (98D with 
concentration [98D]) will also be formed in D2O containing buffers. If we consider a 
reaction run in a D2O containing buffer with mole fractions fH and fD of solvent 
exchangeable H- and D-atoms, then we can write the following rate equations 
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d [86D]/dt = kre fD[97] / 
Dkre,   [1a] 
d [98D]/dt = ksi fD[97] / 
Dksi,   [1b] 
where Dkre and 
Dksi are the solvent deuterium kinetic isotope effects (KIEs) on kre and ksi, 
respectively. It should be pointed out that reaction of 86D with free enzyme to form 97 is 
considered insignificant in this treatment. This will be a reasonable omission, if the primary 
deuterium KIE on H-atom abstraction from C3 is large and [86] is much greater than [86D], 
which was borne out by the experiments. In this system of differential equations, [86D] 
and [98D] change simultaneously so that Eqns. [1a] and [1b] can be combined to eliminate 
dt providing 
d [86D]/d [98D] = kre 
Dksi / (ksi 
Dkre). [2] 
If the solvent deuterium KIEs on net H-atom transfer to the re- and si-faces of 97 are similar 
(i.e., Dkre ≈ Dksi), then Eqn. [2] can be simplified to 
d [86D]/d [98D] = kre / ksi.  [3] 
Because the initial concentrations of 86D and 98D are equal to 0, expression [3] implies 
that the ratio [86D]/[98D] is a constant versus time and expresses the relative partitioning 
of 97 between net H-atom transfer to the re- versus si-faces of the C3-radical (i.e., kre / ksi). 
We can use HPLC peak integrations to measure the fractional concentrations of all 
isotopologs of TDP-D-fucose (denoted f86) and all isotopologs TDP-6-deoxy-D-gulose 
(denoted f98) at some reaction time point. Likewise, we can use mass spectrometry to 
measure the corresponding fractional deuteration of TDP-D-fucose (denoted β86) and TDP-
6-deoxy-D-gulose (denoted β98). These observables then permit calculation of the ratio 
[86D]/[98D] for a given sample according to 
[86D]/ [98D] = f86 β86 / (f98 β98), [4] 
which determines kre / ksi as discussed above. Finally, we can use this ratio to determine the 
relative preference χre of H-atom transfer to the re-face, which we define quantitatively as 
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χre ꞉= ( kre / ksi ) / (1 + kre / ksi). [5] 
A value of 0 or 1 for χre would indicate stereospecific H-atom transfer to the si- or re-face, 
respectively, whereas a value of 0.5 would indicate no stereochemical preference of one 
face over the other. 
In order to obtain the fractional deuterations f86 and β86, the peaks corresponding to 
TDP-D-fucose and TDP-6-deoxy-D-gulose were isolated by HPLC and analyzed by ESI-
MS. The ratio RM of the mass spectroscopic ion signal intensities for a given TDP-sugar, 
i.e., 
RM ꞉= (intensity of [M + 1]) / (intensity of [M]), [6] 
must be corrected for natural abundance heavy isotopes. It is straightforward to show that 
this can be accomplished by subtracting from RM a term α which is just the ratio RM when 
there is no labeling. Applying the correction term, we then have an expression for the 
determination of β for either TDP-sugar, 
β = (RM – α) / (RM – α + 1).  [7] 
The correction term α can also be calculated based on the 1.11% natural abundance of 13C 
providing α = 0.2,1 which will be the same for the two isomers TDP-D-fucose and TDP-6-
deoxy-D-gulose. This calculated value was not significantly different from the measured 
value of 0.18 ± 0.02, which also offers some insight into the precision by which the RM 
ratios could be measured in these experiments. 
Three experimental trials were attempted to measure χre as shown in Table 2-1. 
While the result from the first trial suggested preferential net H-atom transfer to the si-face, 
this was not repeatable in the subsequent trials. It should be noted that this experiment was 
complicated by a solvent deuterium KIE that favored dehydration and/or dehydrogenation 
                                                 
1 Contributions from natural abundance 2H, 15N and 17O were not significant in light of the measurement 
precision. 
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over H-atom transfer in D2O containing buffers. Thus, even at the nearly 80% observable 
reaction in Trial III, only approximately 10% deuteration of the residual TDP-D-fucose was 
expected assuming no stereoselectivity. The mean value of χre from the three trials was 0.3 
± 0.1 (± standard error, standard deviation is 0.2). Therefore, net H-atom transfer to the C3 
radical does not appear to be stereospecific, though there may be a small selectivity for the 
si-face. 
 
Table 2-1.   Results from three trials to measure relative partitioning of H-atom transfer to 
the re- versus si-face of the C3 radical of TDP-D-fucose during reaction with 
DesII. The correction factor α for natural abundance 13C was 0.2 in all cases. 
RM,86 and RM,98 are the respective RM ratios measured for TDP-D-fucose and 
TDP-6-deoxy-D-gulose post reaction. Values in parentheses for RM,86 – α 
represent the expected values for this measurement in the given experiment 
assuming χre = 0.5 (i.e., no stereoselectivity of net H-atom transfer). All 
values are listed arbitrarily to three decimal places. 
Parameter Trial I Trial II Trial III 
f86 0.432 0.532 0.227 
f98 0.080 0.080 0.029 
RM,86 – α 0.009 (0.130) 0.039 (0.054) 0.095 (0.115) 
RM,98 – α 1.669 0.507 4.222 
f86 β86 / f98 β98 0.082 0.738 0.841 
χre 0.075 0.425 0.457 
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2.2.7 Radical Trap Experiments with TDP-D-fucose 
The DesII reaction was also performed in the presence of the radical trap 5,5-
dimethyl-1-pyrroline-N-oxide (DMPO) to further interrogate the solvent accessibility of 
the substrate radical derived from TDP-D-fucose. 15 μM DesII was incubated at room 
temperature for 6 h in a reaction mixture containing 0.5 mM SAM, 0.25 mM TDP-D-fucose 
(86), and 0.5 mM Na2S2O4 in the presence and absence of 100 mM DMPO. Each sample 
was analyzed by HPLC, and any new peaks were collected, lyophilized and analyzed by 
ESI-MS. 
 
 
2.3 RESULTS AND DISCUSSION 
 
2.3.1 DesII Reaction with TDP-4-amino-4-deoxy-D-fucose (85)  
TDP-4-amino-4-deoxy-D-fucose (85) is a C4 epimer of the natural substrate of 
DesII (i.e., TDP-4-amino-4,6-dideoxy-D-glucose (40)), which was designed to test the 
effect of the stereochemical change at C4. Compound 85 was chemically synthesized with 
a deuterium introduced at C3 (85D, see Figure 2-11) in order to test for H-atom abstraction 
at C3 when the stereochemical configuration at C4 is altered. The consumption of both 
85D and SAM was observed upon incubation with DesII (Figure 2-9). The formation of 
5′-deoxyadenosine (5′-dAdo) was indicative of the reaction progress, and the incorporation 
of deuterium into 5′-dAdo was observed by MS consistent with C3-centered radical 
generation (Figure 2-10, A; calculated for C10H11DO3N5
– [M – H]–: 251.1008 m/z, found: 
251.1 m/z). In addition to 5′-dAdo, a new product was observed by HPLC at a retention 
time of 26.9 min. The new product co-eluted with the deamination product 41 from the 
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DesII reaction with 40, indicating that DesII can recognize 85 as a substrate and can 
catalyze the deamination reaction (see Figure 2-11). The specific activity of DesII toward 
85 was not measured. No other TDP-sugar product was observed by HPLC. The level of 
deuteration of residual 85D determined by MS remained the same after incubation with 
DesII for 6 h (ca. 95%, Figure 2-10, B; calculated for C16H25DO14N3P2
– [M – H]–: 547.0958 
m/z, found: 547.1 m/z; calculated for C16H24DO14N3P2Na
– [M – 2H + Na]–: 569.0778 m/z, 
found: 569.1 m/z), suggesting that there was no hydrogen/deuterium exchange at C3 of 85.  
      
 
Figure 2-9.   HPLC traces showing the consumption of TDP-[3-2H]-4-amino-4-deoxy-D-
fucose (85D) and SAM in the presence of DesII and Na2S2O4. Trace 1 was 
measured after 30 min without DesII. Traces 2 and 3 were measured after 2 
h and 6 h in the presence of DesII, respectively. Trace 4 was the same as 
trace 2 coinjected with a DesII reaction with TDP-4-amino-4,6-dideoxy-D-
glucose (40) for 30 min. The retention times in traces 2, 3, and 4 are shifted 
by 1, 2, and 3 min compared to trace 1. Peak A corresponds to the 
methylthioadenosine (MTA) decomposition product of SAM.94 Peak B 
corresponds to a contaminant in the SAM reagent. 
 57 
 
 
 
Figure 2-10.  ESI-MS (negative ion mode) of A: 5′-dAdo generated from the DesII 
reaction with 85D, B: residual 85D, C: residual 85D after reduction by 
NaBH4.    
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Although it seemed that DesII does not catalyze the dehydrogenation of 85 as 
shown by incubating 85 with DesII alone, this activity could not be completely ruled out, 
because the dehydrogenation product (88, see Figure 2-11), if formed, is expected to be 
unstable. Thus, the possibility of formation of 88 was further investigated by including 
NaBH4 in the reaction mixture. If the dehydrogenation reaction takes place in the presence 
of DesII to generate 88, the addition of NaBH4 would result in the regeneration of 
undeuterated 85. The remaining substrate 85D from the DesII/NaBH4 reaction mixture 
incubated for 6 h was isolated by HPLC for MS analysis, which was shown to be 95% 
deuterated (Figure 2-10, C; calculated for C16H25DO14N3P2
– [M – H]–: 547.0958 m/z, 
found: 547.1 m/z). No decrease in the level of deuteration was consistent with no or 
negligible formation of 88.    
All of the results indicated that TDP-4-amino-4-deoxy-D-fucose (85) with the axial 
amino substituent at C4 is processed by DesII as a substrate (Figure 2-11). 85 undergoes a 
deamination reaction as does the natural substrate 40. The substrate radical generated by 
abstraction of hydrogen at C3 proceeds only to the deamination pathway, and no other 
reaction product such as dehydrogenation or reduction of substrate radical was observed. 
 
 
Figure 2-11.  DesII-catalyzed deamination of 85D. The dehydrogenation product 88 was 
not observed.  
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2.3.2 DesII Reaction with TDP-D-fucose (86) 
TDP-D-fucose (86), the C4 epimer of TDP-D-quinovose (44), was employed as a 
potential substrate of DesII to test the hypothesis that a stereochemical change that may 
permit better hyperconjugation could result in dehydratase activity. Previously, it was 
reported that TDP-D-fucose (86) was not a substrate for DesII.40 However, in light of 
improvements in both reconstitution and handling of the enzyme since that initial report, 
we decided to revisit the question. 
TDP-D-fucose (86) was prepared chemoenzymatically via C6-dehydration of TDP-
D-glucose (38) using the 4,6-dehydratase RfbB followed by reduction of the TDP-6-deoxy-
4-keto-D-glucose product (39) with NaBH4.
40 The consumption of both 86 and SAM and 
the production of 5′-dAdo were only observed upon prolonged incubation (hour time scale) 
with a high concentration of DesII (ca. 10‒20 μM) in the presence of Na2S2O4. This 
corresponded to a specific activity on the order of 5 × 10‒4 μmol·min‒1mg‒1 for 
consumption of 86 versus 1 μmol·min‒1mg‒1 for dehydrogenation of 44 at pH 8.0.43 The 
much lower specific activity of DesII towards 86 helps to explain why it was not previously 
recognized as a substrate.40 
The HPLC analysis of the reaction of DesII with 86 showed that three new products, 
designated as X, Y, and Z in the order of retention time, were generated in addition to 5′-
dAdo (Figure 2-12). The species X had the earliest retention time of 28.4 min. It was found 
that species X was also generated during prolonged incubation of DesII with SAM and 
Na2S2O4 in the absence of 86, while there was no significant formation of 5′-dAdo (Figure 
2-13). If either SAM, DesII or Na2S2O4 was excluded from the reaction mixture, however, 
species X was not formed, suggesting that species X may be a sulfinate adduct of 
deoxyadenosine. The ESI-MS analysis of species X showed signals at m/z 316.1 (positive 
ion X, Figure 2-14, A) and m/z 314.1 (negative ion X, Figure 2-14, B). This is consistent 
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with the formation of 5′-deoxyadenosine-5′-sulfinic acid, which has a calculated 
monoisotopic mass of 315.1 Da. When the dideuterated isotopolog [5′,5′-2H2]SAM was 
used instead of natural abundance SAM, ESI-MS peaks at m/z 318.1 (positive ion Xd, 
Figure 2-14, C) and 316.1 m/z (negative ion Xd, Figure 2-14, D) were observed. Moreover, 
a species with the same HPLC retention time as X could be produced from a 
photoirradiated solution of adenosylcobalamin and Na2S2O4 (unpublished data). Based on 
these observations, species X was assigned as 5′-deoxyadenosyl-5′-sulfinic acid (89) 
generated from SAM (Figure 2-15). The specific activity for the sulfination reaction with 
500 μM Na2S2O4 appeared to be no greater than 2×10‒3 μmol·min‒1mg‒1 in the absence of 
86, and its rate of formation was reduced in the presence of the TDP-sugar. This suggests 
that dithionite can access the DesII active site in the absence of a TDP-sugar and intercept 
the 5′-deoxyadenosyl radical either following or concerted with reductive homolysis of 
SAM. 
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Figure 2-12.  HPLC traces showing the reaction of DesII with TDP-D-fucose (86). Trace 
1 was measured after 2 h without DesII. Traces 2 and 3 were measured after 
30 min and 6 h in the presence of DesII. The retention times in traces 2 and 
3 are shifted by 2 and 4 min compared to trace 1. Three new products (X, Y, 
and Z) are observed as shown in the inset (from trace 3). Peaks A and B 
correspond to MTA and the contaminant in the SAM reagent, respectively. 
Peak C corresponds to thymidine monophosphate (TMP).  
 62 
 
Figure 2-13.  HPLC traces showing the consumption of SAM by DesII in the presence of 
Na2S2O4. Traces 1, 2, 3, and 4 were measured after 30 min, 2 h, 6 h, and 24 
h, respectively. The retention times in traces 2, 3, and 4 are shifted by 2, 4, 
and 6 min compared to trace 1. The formation of X is noted.  
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Figure 2-14.  ESI-MS of A: X (positive ion), B: X (negative ion), C: Xd (positive ion), 
and D: Xd (negative ion). The peak at m/z 338.34 likely corresponds to a 
known contaminant (i.e. erucamide) in the ESI-MS. 
 
 
Figure 2-15.  Conversion of SAM (1) to 5′-deoxyadenosyl-5′-sulfinic acid (89).    
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The formation of sulfinate adducts has been reported in the reactions of two other 
radical SAM enzymes when Na2S2O4 is used to maintain a reduced [4Fe-4S]
1+ cluster. The 
spore photoproduct lyase (SPL) is a radical SAM enzyme that repairs the thymidine dimer 
in DNA (e.g., 90 which is a model compound) generated by UV irradiation to two intact 
thymidines (93).97 A single mutation of a conserved cysteine 141 of SPL resulted in the 
production of a sulfinate derivative of dithymidine monophosphate (94, see Figure 2-16).98 
The atypical radical SAM enzyme Dph2 in diphthamide biosynthesis, which employs a 
SAM-derived 3-amino-3-carboxypropyl (ACP) radical (95) rather than a 5′-deoxyadenosyl 
radical, has also been shown to produce a sulfinic acid derivative of ACP (96, 
homocysteine sulfinic acid) in the absence of substrate (Figure 2-17).99 However, the 
formation of 89 from SAM in the presence of DesII and Na2S2O4 represents the first report 
of trapping of 5′-deoxyadenosyl radical generated by a radical SAM enzyme. 
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Figure 2-16.  Repair of thymidine dimer (90) by SPL and the formation of sulfinic acid 
adduct of dithymidine monophosphate (94) by a mutant of SPL. 
 
 
Figure 2-17.  Formation of homocysteine sulfinic acid (96) in the absence of substrate by 
Dph2. 
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Both of the remaining two product peaks in Figure 2-12 originated from TDP-D-
fucose (86). The major product peak (i.e., Y in H2O buffer) from the DesII reaction with 
TDP-D-fucose had a retention time of 30.5 min. Negative ion ESI-MS analysis of the 
isolated Y showed clear signals indicating [M ‒ H]‒ and [M ‒ 2H +Na]‒ ions at 547.1 and 
569.1 m/z, respectively, which is consistent with an isomer of TDP-D-fucose (Figure 2-18, 
A). However, the assignment of Y as TDP-D-quinovose (44) was ruled out due to the 
different HPLC retention time and relative inertness to DesII catalysis. Species Y was 
relatively stable and collected in quantities suitable for 1H NMR analysis. All coupling 
constants between protons on the hexose ring are relatively small (< 6 Hz) indicating an 
absence of trans-diaxial C‒H bonds (see Chapter 2.2.5 and Figure 2-7). Thus, species Y 
seemed to have a diaxial configuration of the vicinal hydroxyl groups at C3 and C4, and it 
was assigned as TDP-6-deoxy-D-gulose (98), the C3 epimer of TDP-D-fucose. Despite the 
stability of TDP-6-deoxy-D-gulose (98) versus the 3-keto products, the 1H NMR spectra 
nevertheless demonstrated significant contamination due to its decomposition to a 1,2-
cyclic sugar-phosphate and thymidine monophosphate during workup. Therefore, a TDP-
6-deoxy-D-gulose (98) standard was prepared from an incubation of TDP-4-keto-6-deoxy-
D-glucose (39) with FdtA followed by reduction with NaBH4 (see Chapter 2.2.3.3, Figure 
2-3). This yielded a mixture of 86 and 98, which was used to confirm the assignment of Y 
as 98 by both HPLC coinjection and 1H NMR spectroscopy. 
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Figure 2-18.  ESI-MS of A: isolated HPLC peak Y, and B: peak Z in negative ion mode. 
 
 
 
Figure 2-19.  Reactions catalyzed by DesII when TDP-D-fucose (86) serves as the 
substrate.  
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The formation of TDP-6-deoxy-D-gulose (98) from TDP-D-fucose (86) implies that 
the C3 radical intermediate (97, Figure 2-19) is reduced via a net H-atom transfer. In buffer 
containing at least 95% deuterium, an approximately four-fold incorporation of deuterium 
versus protium into the product 98 was observed by ESI-MS. In addition, 98, the major 
distinguishable product (~80%) in H2O, was the minor product in D2O (< 30%) indicating 
a solvent deuterium kinetic isotope effect on the partitioning of 97 between the different 
routes of decomposition. To determine the stereospecificity of net H-atom transfer to 97, 
the deuterium enrichment of the residual TDP-D-fucose in the D2O buffers was analyzed 
(see Chapter 2.2.6). Despite being complicated by the isotope effect disfavoring net H-
atom transfer to 97, small but measurable increases in the deuteration of the residual 
substrate (86) were detected by mass spectrometry. The regeneration of 86 suggested that 
net H-atom transfer is possible to both faces of the C3 radical. Finally, reactions run in the 
presence of the radical trap 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) decreased 
production of all decomposition products, but not consumption of 86, and resulted in two 
new species observable by HPLC with retention times of 17 min and 23 min (Figure 2-20). 
ESI-MS analysis of these collected peaks in both cases demonstrated signals at 660.1 m/z 
(negative ion) as well as 684.2 and 706.1 m/z (positive ions), consistent with [M – H]–, [M 
+ Na]+ and [M – H + 2Na]+ ions, respectively, of a DMPO adduct 99, which would have a 
neutral monoisotopic mass of 661.16 Da. These results implicate that the enzyme‒
intermediate complex is destabilized by the axial substituent at C4 of 86, permitting access 
to the substrate radical 97 by solvent, and that the net H-atom (or electron coupled proton) 
transferred to C3 originates from a solvent-exchangeable source.  
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Figure 2-20.  HPLC trace of DesII reaction with TDP-D-fucose (86) in the presence of 
100 mM DMPO. Two new products corresponding to the DMPO adducts 99 
are observed as shown in the inset. 
 
The species Z with a retention time of 34.3 min coeluted with the deamination 
product 41, and negative ion mode ESI-MS of the collected peak exhibited a clear ion 
signal at 529.1 m/z (see Figure 2-18, B). The identity of peak Z as the dehydration product 
41 was further verified using a coupling reaction with DesV, which catalyzes the reductive 
amination of the C3 keto functionality of 41 in the presence of glutamate during the 
biosynthesis of TDP-desosamine.36 The DesII/DesV coupled reaction with TDP-D-fucose 
(86) demonstrated the formation of two products with retention times of approximately 5.3 
and 5.8 min, respectively, concomitant with the consumption of peak Z (Figure 2-21, Trace 
1). The first HPLC peak of the two products coeluted with TDP-3-amino-3,4,6-trideoxy-
D-glucose (42) produced in DesII/DesV reaction with TDP-4-amino-4,6-dideoxy-D-
glucose (40) (Figure 2-21, Trace 2). These observations indicated that DesII is indeed 
 70 
capable of operating as a dehydratase when the stereochemistry at C4 of TDP-D-quinovose 
(44) is inverted. 
 
 
 
Figure 2-21.  HPLC traces of coupled DesII/DesV reactions with TDP-D-fucose (86) 
along with coinjections with standard C3-amino TDP-sugars. Trace 1: 
DesII/DesV/TDP-D-fucose reaction; Trace 2: same as Trace 1 coinjected 
with a reaction of DesII/DesV/TDP-4-amino-4,6-dideoxy-D-glucose (40); 
Trace 3: same as Trace 1 coinjected with TDP-3-amino-3-deoxy-D-fucose 
(101). Retention times in Traces 2 and 3 are shifted by 2 and 4 min, 
respectively. The inset shows an expanded, unshifted view of the 4.5–6.5 
min range where 42 and 101 elute.  
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The second product from DesII/DesV coupled reaction system was formed in a 
roughly equal quantity to 42, and its retention time was also consistent with a TDP-
aminosugar. Negative ion ESI-MS analysis of the second peak showed a signal at 546.1 
m/z suggesting the [M ‒ H]‒ ion of TDP-3-amino-3-deoxy-D-fucose (101). To confirm this 
assignment, a standard of compound 101 was prepared from TDP-6-deoxy-4-keto-D-
glucose (39) using the 3,4-ketoisomerase FdtA from Aneurinibacillus thermoaerophilus in 
combination with DesV.90,100 This standard 101 indeed coeluted by HPLC with the second 
DesII/DesV product from the TDP-D-fucose reaction (see Figure 2-21, Trace 3). The 
formation of both 42 and 101 in an approximately 1:1 ratio in the DesII/DesV reaction 
implies that the substrate radical 97 partitions between dehydration and dehydrogenation 
in a roughly equal extent without racemization at C4. It should be noted that the 
dehydrogenation product TDP-3-keto-D-fucose (100) was not directly observed during the 
reaction of DesII alone presumably due to the poor stability of 3-keto TDP-sugars.92  
To summarize, TDP-D-fucose (86) can be recognized as a substrate for DesII 
despite having the inverted stereochemistry at C4 as compared to the equatorial hydroxyl 
group at C4 of TDP-quinovose (44). The majority of substrate radical 97 undergoes 
epimerization at C3 to generate TDP-6-deoxy-D-gulose (98) and likely the regeneration of 
86 via net H-atom return from a solvent-exchangeable source. The remainder of 97 results 
in an approximately equal competition between elimination and dehydrogenation pathways 
(see Figure 2-19). These results imply that the partitioning of the substrate radical leading 
to different reaction outcomes is determined in at least in part by the stereochemical 
configuration of the radical intermediate.  
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2.3.3 DesII Reaction with TDP-6-deoxy-D-mannose (87) 
The fact that DesII does not catalyze the elimination of the hydroxyl at C2 in either 
TDP-4-amino-4,6-dideoxy-D-glucose (40) or TDP-D-quinovose (44) is hypothesized to be 
due to the orthogonal orientation of the C2 substituent in the enzyme active site as observed 
by EPR characterization of the radical intermediate generated from 44.42 This hypothesis 
suggests that dehydration of the C2 center may take place if overlap between the C2–OH 
σ-bond and the p-orbital at C3 is increased by a conformational change in the radical 
intermediate. In this respect, TDP-6-deoxy-D-mannose (87), the C2 epimer of 44 in which 
the C2 hydroxyl group is in axial position, was tested as a potential substrate for DesII. 
Similar to TDP-4-amino-4-deoxy-D-fucose (85), a deuterium was introduced at C3 of 87 
(87D, see Figure 2-24) as a probe to monitor the reaction progress. 
The consumption of SAM and the production of 5′-dAdo were observed upon 
incubation of DesII with 87D and SAM in the presence of Na2S2O4 (Figure 2-22). It 
appeared that SAM was consumed more rapidly compared to 87D in the presence of DesII 
as estimated from changes in the HPLC peak intensities. Accordingly, 5′-dAdo generated 
from DesII catalysis over a 6 h incubation was not completely deuterated (see Figure 2-23, 
A and B). The deuterium content of 5′-dAdo measured by ESI-MS was 80% and 54% in 
two individual trials, which suggested the uncoupled cleavage of SAM. The uncoupled 
reductive homolysis of SAM is commonly observed with radical SAM enzymes in the 
absence of substrate.3,101 In both trials, the residual 87D after reaction remained deuterated 
(ca. >95%, Figure 2-23, C and D; calculated for C16H24DO15N2P2
– [M – H]–: 548.0798 m/z, 
found: 548.1 m/z; calculated for C16H23DO15N2P2Na
– [M – 2H + Na]–: 570.0618 m/z, 
found: 570.1 m/z). The formation of 5′-deoxyadenosyl-5′-sulfinic acid (89) was also 
observed.  
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Figure 2-22.  HPLC traces of DesII reaction with TDP-[3-2H]-6-deoxy-D-mannose (87D). 
Trace 1 was measured after 30 min without DesII. Traces 2, 3, and 4 were 
measured after 30 min, 4 h, and 22 h in the presence of DesII, respectively. 
The retention times in traces 2, 3, and 4 are shifted by 2, 4, and 6 min for 
presentation purposes. The consumption of 87D and SAM along with the 
production of 5′-dAdo and TDP was observed. The production of 5′-
deoxyadenosyl-5′-sulfinic acid (89) was also noted. 
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Figure 2-23.  ESI-MS of A, B: 5′-dAdo generated from the DesII reaction with 87D in 
two individual trials (positive ion mode), C, D: residual 87D after 6 h in two 
individual trials (negative ion mode). 
While there was no observable TDP-sugar products, TDP was generated during the 
catalysis (calculated for C10H15O11N2P2
– [M – H]–: 401.0157 m/z, found: 401.0 m/z). TDP 
was not formed without DesII under the same reaction condition. The fractional conversion 
of 87D to TDP estimated by the HPLC peak intensity was approximately 20% after 6 h, 
which is considered significant compared to less than 5% production from the DesII 
reaction of TDP-D-quinovose (44). It was previously reported that a TDP sugar with a C3 
ketone functionality decomposes to yield the dihydropyran likely by deprotonation at C2 
followed by elimination of TDP.92 Thus, the formation of TDP from 87D by DesII 
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suggested that a TDP-3-keto-sugar may be produced during the catalysis by DesII, and 
readily decomposes to generate a dihydropyran and TDP. The possible immediate products 
from the DesII reaction with 87D and their degradation products are shown in Figure 2-24. 
The dehydrogenation reaction that is similar to the reaction of TDP-D-quinovose with DesII 
would produce TDP-3-keto-6-deoxy-D-mannose (102) that is degraded to (2R,3R)-2-
methyl-3,5-dihydroxy-4-keto-2,3-dihydropyran (105) by eliminating TDP. In contrast, 
dehydration at C2 would initially produce TDP-3-keto-2,6-dideoxy-D-glucose (103) and 
then proceed to degradation to form (2R,3R)-2-methyl-3-hydroxy-4-keto-2,3-
dihydropyran (106). Another possibility would be the formation of the C4 dehydration 
product 104; however, it is less likely considering that the dehydration at C4 of TDP-D-
quinovose (44) is not observed.40,41   
   
 
 
Figure 2-24.  Possible reaction products from the DesII reaction with 87D. 
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In an effort to characterize the TDP sugar product in the reaction between DesII 
and 87D, a DesV coupled assay was performed. This resulted in only a tiny peak observed 
by HPLC that may correspond to a TDP-amino sugar; however, ESI-MS of this new 
compound did not yield any detectable signal due to low concentration. The limited 
conversion and rapid degradation also made the attempt to reduce the 3-keto sugar product 
by NaBH4 unsuccessful. Instead, an effort was made to characterize the degradation 
product(s). A standard of dihydropyran 105 was enzymatically prepared from TDP-D-
glucose (38) using RfbB and Tyl1a according to the published procedure.92 A standard of 
compound 106 was chemically synthesized. 
Standards 105 and 106 eluted very early with the retention times of less than 2 min 
when analyzed by anion exchange HPLC,92 which complicated the ESI-MS analysis due 
to many other components in the reaction mixture that elute in this region. HPLC analysis 
using a C18 column resulted in longer retention times and thus better resolution of 105 and 
106 (see Figure 2-25). When the reaction mixture with DesII and 87D was analyzed under 
the same condition using C18 column, however, there was no peak having the same 
retention time as 105 or 106. Guided by the elution profile of standard compounds, the 
elution fraction expected to contain the degradation product(s) was collected and analyzed 
by ESI-MS in positive ion mode. Neither 105 nor 106 was detected. The major species 
found in the reaction mixture was adenine (calculated for C5H6N5
+ [M + H]+: 136.0623 
m/z, found: 136.1 m/z), which was observed by HPLC with a retention time of 14.7 min. 
The characterization of degradation products 105 and 106 by ESI-MS turned out to be 
challenging due to their intrinsic weak ionization, which was further compounded by the 
presence of contaminant(s). The identity of the degradation product is currently being 
investigated. 
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Figure 2-25.  HPLC trace of DesII reaction with 87D analyzed using C18 HPLC. Traces 
1 and 2 show the injection of the standard compounds 105 and 106, 
respectively. The DesII reaction with 87D in the presence of SAM and 
Na2S2O4 after 4 h is shown in trace 3. The production of 5′-dAdo and MTA 
(peak A) was noted. The broad peak eluting at 14.7 min (peak D) was found 
to be adenine. The traces from 8 min to 18 min are shown enlarged in the 
inset. 
 
  
 78 
2.3.4 Mechanistic Implications 
While structural information on the active site of DesII is not available yet, the dual 
activities of DesII capable of catalyzing both deamination and dehydrogenation may be 
explained at least in part by the geometric configuration of the substrate in the active site. 
In the case of TDP-D-quinovose (44), its C3-centered substrate radical is assumed to bind 
in a chair-like conformation, which results in poor hyperconjugation between the p-orbital 
at the radical center and the adjacent C–O bonds at both C2 and C4. Stalling of the catalytic 
cycle for the elimination reaction allows an active site base residue to deprotonate the C3 
hydroxyl group facilitating the oxidation of radical intermediate by electron transfer back 
to the [4Fe-4S] cluster. In contrast, it is hypothesized that the radical intermediate derived 
from the biosynthetically relevant substrate TDP-4-amino-4,6-dideoxy-D-glucose (40) 
adopts a different binding configuration due to the protonated amino group at C4. If correct, 
the periplanar configuration between the p-orbital and the C4 amino group would account 
for the observed lyase activity of DesII.  
The deamination reaction of TDP-4-amino-4-deoxy-D-fucose (85) catalyzed by 
DesII supports the current working model that the partitioning of radical intermediates 
depends at least in part on the binding configuration. Despite the inverted stereochemistry 
at C4, the presence of protonated amino group may reinforce the alternative binding 
configuration that optimizes the orbital overlap required for elimination reaction, while 
maintaining the orthogonal orientation with respect to the C2 substituent. There was no 
evidence for dehydrogenation taking place, suggesting that partitioning into the 
deamination pathway is significantly greater than oxidation of the radical intermediate. 
Moreover, the fact that the deuterium at C3 of 85D is not exchanged implies that forward 
partitioning to elimination of the C4 amino group is fast compared to either the reverse 
reaction or quenching of the substrate radical by a solvent-accessible source. The course of 
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the DesII reaction with 85 contrasts with the reaction of C3-fluorinated substrate analogs 
(i.e., TDP-[3-2H]-4-amino-3,4,6-trideoxy-3-fluoro-D-glucose and TDP-[3-2H]-3,6-
dideoxy-3-fluoro-D-glucose) employed in a separate study. It was shown for C3-
fluorinated analogs that the hydrogen atom abstraction by 5′-dAdo to form the substrate 
radical intermediate is reversible, and that the reverse reaction to regenerate SAM and 
substrate dominates when forward partitioning is impeded.102  
The DesII reaction with TDP-D-fucose (86) demonstrates the diverse reaction 
pathways available to a radical intermediate. Upon inversion of stereochemistry at C4, the 
binding interaction between the enzyme and the radical intermediate from 86 is presumed 
to be destabilized, predominantly leading to the reduction of substrate radical via net H-
atom transfer. In addition, a roughly equal partitioning between dehydration and 
dehydrogenation without racemization at C4 was observed. The dehydratase activity of 
DesII with 86 implies that perturbations of the stereochemistry can induce C–O bond 
cleavage, arguing against the hypothesis that dehydration is slow due entirely to the poor 
leaving group ability of hydroxyl group. These results support the mechanistic hypothesis 
in which the fate of the radical intermediate is governed at least in part by stereochemical 
configuration.  
The reaction outcome of incubation of DesII and TDP-6-deoxy-D-mannose (87) is 
of particular interest due to the inversion of stereochemistry at C2 position. While 87 can 
be processed by DesII as a substrate, the key question whether or not the C2 hydroxyl 
group is eliminated has not been answered yet. The TDP sugar product formed from the 
reaction appears to be unstable because of the C3 ketone functionality in accord with the 
previous report.92 Nevertheless, the formation of 5′-dAdo with the deuterium incorporated 
indicates the relaxed substrate specificity of DesII that can recognize the alternative 
substrate with the C2 axial substituent. The reverse reaction to regenerate the substrate 
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from the substrate radical seems to be hindered as reflected by the retention of deuterium 
on the residual substrate 87D. Further experiments are required to fully characterize the 
degradation product, from which the structure of the initial TDP sugar product can be 
deduced. 
     
 
2.4 CONCLUSION 
DesII is the radical SAM enzyme that catalyzes the deamination reaction leading 
to C4 deoxygenation during the biosynthesis of TDP-desosamine (43) in S. venezuelae. 
While it operates as a lyase that eliminates the C4 amino group of TDP-4,6-dideoxy-3-
keto-D-glucose (40) in the desosamine biosynthetic pathway, DesII can catalyze an 
oxidation reaction when TDP-D-quinovose (44) is provided as the substrate. The principle 
underlying discrimination between the deamination and dehydrogenation pathways has 
been studied by employing several substrate analogs with inverted stereochemistry at C2 
or C4. DesII catalyzes the deamination of TDP-4-amino-4-deoxy-D-fucose (85), the C4 
epimer of 40 which bears an axial amino substituent. This is consistent with the current 
mechanistic hypothesis for deamination and the proton transfer steps it entails. In the DesII 
reaction with TDP-D-fucose (86) as a substrate, the majority of the reaction flux results in 
epimerization at C3. However, the remainder leads to both dehydration and 
dehydrogenation products to an approximately equal extent, indicating that stereochemical 
perturbations in the substrate allow partitioning into the elimination pathway. TDP-6-
deoxy-mannose bearing a C2 axial hydroxyl group (87) can also be recognized by DesII as 
a substrate, although the initial TDP-sugar product appears to be readily degraded. The 
identity of the degradation product is currently being investigated. Taken together, it 
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appears that DesII exhibits a relaxed substrate specificity regarding the stereochemistry at 
C2 and C4 positions despite lower catalytic efficiency. These results are consistent with 
the hypothesis that substrate geometry in the active site plays an important role in 
controlling the fate of radical intermediates during the catalytic cycle of DesII. 
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Chapter 3:  Biosynthetic Studies of Formycin A and Coformycin 
 
3.1 INTRODUCTION 
Formycin A (51) is a C-nucleoside analog of adenosine (53), isolated from 
Nocardia interforma and Streptomyces kaniharaensis SF-557 (Figure 3-1).51,52 Formycin 
A is characterized by the C-glycosidic linkage between ribose and the unique 
pyrazolopyrimidine nucleobase, compared to its N-nucleoside counterpart adenosine with 
an imidazolopyrimidine nucleobase. The formycin-producing strains also produce another 
nucleoside metabolite, coformycin (108), which possesses an unusual 1,3-diazepine 
ring.52,103 Although coformycin alone has no antibacterial activity, the presence of 
coformycin potentiates the activity of formycin A by inhibiting the adenosine deaminase 
that converts formycin A into the inactive analog formycin B (52).104 A similar synergetic 
relationship is found between 2′-deoxycoformycin (109, pentostatin or NipentTM) and 
vidarabine (110, 9-β-D-arabinofuranosyladenine), isolated together from Streptomyces 
antibioticus.105 While 2′-deoxycoformycin (109) is an anticancer drug used for treatment 
of hairy cell leukemia,106 vidarabine (110) is an antiviral nucleoside active against herpes 
simplex virus.107 The D-ribose of adenosine (53) is replaced with D-arabinose in 110, which 
results in competitive incorporation of 110 into DNA to interfere with viral DNA 
synthesis.108 The antiviral activity of 110 is enhanced by 109 due to the inhibitory effect of 
109 on adenosine deaminase.108,109  
 
                                                 
 The part of this chapter has been submitted for publication and under review. I was the primary author 
(Ko, Y.; Wang, S.-A.; Ogasawara, Y.; Ruszczycky, M. W.; Liu, H.-w. Identification and characterization of 
enzymes catalyzing pyrazolopyrimidine formation in the biosynthesis of formycin A. submitted). 
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Figure 3-1.   Structures of formycin A (51) and several related compounds: formycin B 
(52), adenosine (53), coformycin (108), 2′-deoxycoformycin (109), and 
vidarabine (110).   
 
Various enzymes that recognize adenosine (53) as a substrate are inhibited by 
formycin A (51) due to their close structural similarity. Formycin A and its analogs have 
been shown to be a potent inhibitors of bacterial purine nucleoside phosphorylase, whereas 
they are inactive against mammalian enzymes.110,111 Likewise, formycin A inhibits 
adenosine kinase from Mycobacterium tuberculosis, which is involved in the purine 
salvage pathway,112 and E. coli 5′-methylthioadenosine (MTA)/S-adenosylhomocysteine 
(SAH) nucleosidase, which is involved in the catabolism of MTA and SAH.113 Therefore, 
formycin A is of interest for its potential in selective drug design. Furthermore, it has been 
reported that formycin A exhibits antiproliferative properties with respect to various cancer 
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cells114,115 and antiviral activity against influenza virus A14116 and human 
immunodeficiency virus type 1.117  
Although extensive research has been devoted to study the biological activities of 
formycins, investigation of their biosynthesis has been rare and slow. Early in vivo and in 
vitro studies have shown that the pyrazolopyrimidine ring of formycin A is derived from 
L-glutamate (75) and L-lysine (76),68-70 and formycin B 5′-phosphate (77) is a likely 
intermediate in the biosynthetic pathway of formycin A (see discussion in Chapter 1.2.3).66 
However, the biosynthetic gene cluster and enzymes responsible for such transformations 
between these precursors and the final product have not yet been identified. 
The biosynthesis of coformycin (108) is presumed to be associated with that of 
formycin A given their similar production profiles from the same bacterial strain and their 
synergetic biological activities. The diazepine ring found in coformycin (108) and its 
derivatives rarely occurs in nature. In vivo isotope labeling experiments in S. antibioticus 
indicated that the methylene group at C7 of 2′-deoxycoformycin (109) is derived from the 
C1 of ribose, and the possibility that inosine (54) is a direct precursor of 109 has been ruled 
out.118,119 In addition, cell-free extracts of S. antibioticus were shown to be capable of 
catalyzing the reduction of 8-ketocoformycin (119) and 8-ketodeoxycoformycin (120) in 
the presence of NADPH. Taken together, the above observations led to the proposed 
biosynthetic pathway of coformycin (108) and 2′-deoxycoformycin (109, see Figure 3-
2).120 The early steps of the proposed pathway are similar to the biosynthesis of L-histidine 
(111, 112 → 116),121 which begin with the coupling of PRPP (74) and adenosine 5′-
triphosphate (111, ATP), or 2′-deoxyadenosine-5′-triphosphate (112, dATP) in the case of 
109. Dephosphorylation followed by ring cleavage generates the intermediate 115. An 
Amadori-type rearrangement of 115 leads to the formation of intermediate 116, and then 
the 1,3-diazepine ring is formed via an aldol-like mechanism. Elimination of four-carbon 
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chain, dephosphorylation, and reduction of the ketone group produces 108 or 109. 
Although the non-phosphorylated 8-keto compounds (119 and 120) were identified as the 
biosynthetically relevant intermediates, whether the dephosphorylation is followed by the 
reduction, or vice versa, is not known. 
Chapter 3 describes biosynthetic studies of formycin A (51) and coformycin (108). 
In order to discover the biosynthetic gene cluster for formycin A (51), the genome of S. 
kaniharaensis was sequenced. The preliminary genomic analysis revealed two sets of pur 
homologous genes, which are involved in the later stage of the biosynthesis of adenosine 
5′-monophosphate (127, AMP). This finding led to the hypothesis that the assembly of the 
pyrimidine ring in both formycin A and AMP follows a similar pathway. A cosmid library 
was constructed and screened for the second copy of pur genes according to the hypothesis. 
As a result, one cosmid was identified to harbor the second set of pur genes and likely the 
entire gene cluster of formycin A. Bioinformatics analysis permitted assignment of putative 
functions to each gene, from which a biosynthetic pathway for formycin A could be 
proposed. The conversion of carboxyaminopyrazole ribonucleotide (128) to formycin A 
(51) was demonstrated by incubation using Pur-like enzymes encoded in the gene cluster. 
Moreover, one of the genes flanked by the end of the putative gene cluster of formycin A 
was shown to encode an NADPH-dependent reductase that catalyzes the last step of the 
biosynthesis of coformycin. Ultimately, this research aims to elucidate the complete 
biosynthetic pathway of formycin A and coformycin, and examine the detailed reaction 
mechanisms of the enzymes involved. 
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Figure 3-2.   Proposed biosynthesis of coformycin and deoxycoformycin.  
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3.2 EXPERIMENTAL PROCEDURES 
 
3.2.1 General 
Kits for isolation of genomic DNA and plasmid DNA were purchased from Life 
Technologies (Carlsbad, CA) and Qiagen (Hilden, Germany), respectively. A kit for 
construction of cosmid libraries was purchased from Agilent Technologies (Santa Clara, 
CA). Formycin A (51) was purchased from Berry & Associates, Inc (Dexter, MI). All 
chemicals and reagents were purchased from Fisher Scientific (Pittsburgh, PA) or Sigma-
Aldrich (St. Louis, MO), and were used without further purification unless otherwise 
specified. 
The bacterial strains Streptomyces kaniharaensis (ATCC21070) and Streptomyces 
antibioticus (NRRL 3238) were obtained from the American Type Culture Collection and 
the Agricultural Research Service Culture Collection, respectively. E. coli DH5α and E. 
coli BL21 Star (DE3) from Invitrogen (Carlsbad, CA) were used as the host for routine 
cloning and heterologous protein expression.  
The genomic DNA of Streptomyces kaniharaensis SF-557 was sequenced using a 
Roche 454 sequencer at the Genomic Sequencing and Analysis Facility (GSAF) at the 
University of Texas at Austin. Routine DNA sequencing was performed by the Institute 
for Cellular and Molecular Biology Core Facilities at the University of Texas at Austin. 
All high-resolution mass spectrometry (HRMS) was performed at the Mass Spectrometry 
Facility (MSF) of the Department of Chemistry, University of Texas at Austin. Standard 
genetic manipulations of E. coli were performed as described by Sambrook and Russell.122 
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3.2.2 Genomic Sequencing of S. kaniharanesis 
Approximately 30 μg of genomic DNA of S. kaniharaensis was isolated using 
PureLink genomic DNA kits according to the manufacturer’s protocol. The isolated 
genomic DNA was sequenced using a Roche 454 sequencer at the GSAF which resulted 
in 3011 contiguous sequences (contigs) with an average size of 2641 bp. The MIRA 
program was used to assemble the contigs,123 and ORFs were defined with Glimmer using 
a hidden Markov model to yield 9527 open reading frames (ORFs) in total.124 The a 
biological function for each ORF was proposed based on BLAST searches. 
 
3.2.3 Construction and Screening of the Cosmid Library 
The vector pOJ446 was digested with HpaI and treated with calf intestinal alkaline 
phosphatase (CIP). After purification, pOJ446/HpaI/CIP was digested with BamHI. The 
genomic DNA of S. kaniharaensis was partially digested by Sau3AI and then purified by 
phenol/chloroform/isoamyl alcohol (PCI) extraction, chloroform extraction, and isopropyl 
alcohol precipitation. The partially digested genomic DNA was treated with CIP and 
purified by PCI extraction, chloroform extraction, and isopropyl alcohol precipitation. The 
partially digested genomic DNA was ligated with the pOJ446/HpaI/CIP/BamHI vector. 
The ligated DNA was packaged into phage particles using Gigapack III XL packaging 
extract and introduced into E. coli XL1-Blue MRF′ according to the manufacturer’s 
protocol. The cells were plated onto Luria broth (LB) agar and selected by using apramycin 
(50 µg/mL). The positive colonies were collected in LB containing apramycin (50 µg/mL), 
incubated at 37 °C overnight, and stored at –80 °C with 20% glycerol. 
For screening, the positive colonies harboring the cosmid library were grown at 37 
°C overnight and DNA was obtained by miniprep. The cosmid library was screened by 
polymerase chain reaction (PCR). The primers used were: 5′-GCTGGCCTGATC-
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CGCGAACC-3′ (forward for purA homolog), 5′-GCCGATGGTCCGGTCCACGC-3′ 
(reverse for purA homolog), 5′-CCAGTTCTCCGTCGCACTCG-3′ (forward for purC 
homolog), 5′-TGCAGACCGGGGTCCCTCGG-3′ (reverse for purC homolog), 5′-
GTGCGGCGTCCACGACCAGG-3′ (forward for purH homolog), 5′-GCTGGAGGG-
TCGCGGCCACG-3′ (reverse for purH homolog).  
The K24C cosmid was found to contain all purA, purC, and purH homologs, and 
the K5B cosmid was found to contain the purC homologous gene. Thus, the K24C cosmid 
was subjected to sequencing by primer walking, and the results were assembled using 
MIRA. ORFs were defined by Glimmer and each gene was annotated based on a 
comparison with the non-redundant database using BLAST. 
The obtained sequences of purA, purB, purC, and purH homologous genes were 
compared to the known sequences of adenosine 5′-monophosphate (AMP) biosynthetic 
genes found in Streptomyces coelicolor A3(2), Streptomyces griseus subsp. Griseus NBRC 
13350, Streptomyces avermitilis MA-4680, and Streptomyces scabiei 87.22 by BLAST. 
The locus tags used for analysis were: SCO3629, SGR_RS16855, SAV_4547, and 
SCAB_RS19930 for adenylosuccinate synthetase (purA); SCO1254, SGR_RS31355, 
SAV_7077, and SCAB_RS37365 for adenylosuccinate lyase (purB); SCO4071, 
SGR_RS19105, SAV_4146, and SCAB_RS22720 for phosphoribosylaminoimidazole-
succino-carboxamide synthase (purC or hemH); SCO4814, SGR_RS13410, SAV_3444, 
and SCAB_RS16940 for bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase (purH). 
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3.2.4 Cloning and Expression of Enzymes Encoded in the Biosynthetic Gene Cluster 
of Formycin A 
Each gene in the putative biosynthetic gene cluster of formycin A was PCR 
amplified from the K24C cosmid and cloned into the pET28b(+) vector unless otherwise 
specified. The primers used in this study are listed in Table 3-1.  
Expression of recombinant proteins was routinely performed as described below, 
unless otherwise specified. E. coli BL21 Star (DE3) cells were transformed with the 
resulting plasmid and grown at 37 °C in LB medium containing kanamycin (30 μg/mL). 
The overnight culture was used to inoculate 3 L of the same medium in a 100-fold dilution. 
These cultures were incubated at 37 °C until OD600 reached between 0.4–0.6. Protein 
expression was induced by the addition of isopropylthiogalactoside (IPTG) to a final 
concentration of 0.2 mM. After overnight incubation at 18 °C, the cells were harvested by 
centrifugation at 4500 × g for 8 min, resuspended in 80 mL of 100 mM Tris buffer (pH 
8.0) containing 300 mM NaCl, and disrupted by sonication. Cell debris was removed by 
centrifugation at 20000 × g for 30 min, and the supernatant was mixed by slow agitation 
with 5 mL of nickel-nitrilotriacetic acid (Ni-NTA) resin for 10 min at 4 °C. The slurry was 
transferred to a column and washed with 50 mL of 100 mM Tris buffer (pH 8.0) containing 
300 mM NaCl and 20 mM imidazole. The protein was eluted with 25 mL of 100 mM Tris 
buffer (pH 8.0) containing 300 mM NaCl and 250 mM imidazole, and dialyzed three times 
against 1 L of 100 mM Tris buffer (pH 8.0) containing 300 mM NaCl and 10–20% glycerol 
prior to storage at –80 °C.  
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Table 3-1.   Primers for cloning used in this study (restriction sites underlined). 
Gene Forward primer Reverse primer 
orf -2 5′-TTAATTGGCATATGGGTGAGCCT-3′ 5′-AGAGAATTCAGACGTGCTGGAG-3′ 
orf -1 5′-TTCCTTCACATATGACTTCCCGTACTCC-3′ 5′-AAAGAATTCACCCACCGGAGACC-3′ 
forA 5′-GCCATCCTCATATGTCCGAGCGAG-3′ 5′-CGAGAATTCAGCGCGGCGG-3′ 
forB 5′-ATTATCCACATATGACCGGCCTGG-3′ 
5′-AACTCTCGAGTCAGCTCCTCTCC-3′ 
(for pET-28b(+) vector), 
5′-AAATCTCGAGGCTCCTCTCCGC-3′ 
(for pET24b(+) vector) 
forC 5′-ATAAAGTCCATATGCTGGCCGTACTCG-3′ 5′-GCAGAATTCACGACCGGCTCC-3′ 
forD 5′-AATAAGTCCATATGCTGAAGGCAATCG-3′ 5′-CAGGAATTCTACTTGATCTCGATCAGC-3′ 
forE 5′-TAAATAGCCATATGCGACCCACCG-3′ 5′-GGAGAATTCAGGCCAGCAGC-3′ 
forG 5′-AAAAAATACATATGATCACCGAGAAGTCC-3′ 5′-AAAGAATTCAGGCCCGGCC-3′ 
forH 5′-TTTTTCCACATATGACCGTTCCACG-3′ 5′-TTCTCTCGAGTCAGTGCGATGG-3′ 
forI 5′-TTGAGTGACATATGAGTGAGATGC-3′ 5′-AAAGAATTCAGCGCCCCGTG-3′ 
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Table 3-1. Continued. 
 
forJ 5′-AAAAAGAACATATGAAGGCGGCG-3′ 
5′-CCAGAATTCAGCCGATCTCG-3′ 
(for pET-28b(+) vector), 
5′-AAAACTCGAGGCCGATCTCGTGC-3′ 
(for pET-24b(+) vector) 
forK 5′- AAAAAAGGCATATGGCGAAGCGC-3′ 5′-TTATCTCGAGCTACTCTCCGTCG-3′ 
forP 5′-TTATTCCACATATGACCCGGATCATCGTC-3′ 5′-TTAGAATTCACGCCGCCACGAAG-3′ 
forQ 5′-ATAATAGCCATATGCGACAGGTTG-3′ 5′-ATAGAATTCACCGCTGCTCC-3′ 
forR 5′-TACAAGAACATATGAAGACCGACATCC-3′ 5′-AGAGAATTCAGAGCAGCGGG-3′ 
forS 5′-AATTAACGCATATGGCACTTGACCGACCC-3′ 5′-GGAGAATTCAGGAGACGACGGTGG-3′ 
forT 5′-TAAAATCACATATGGCTACGCGGAAGG-3′ 5′-ACAGAATTCAGGACACCAGGTCG-3′ 
forU 5′-CAAAATCTCATATGGCCCATGTGC-3′ 5′-AAAGAATTCAGGCGGAGGTGG-3′ 
forV 5′-AATAAGAACATATGAAGCGCTGGTCC-3′ 5′-GATGAATTCTAGTCGGCCGAAGC-3′ 
forW 5′-ATTATTAGCATATGGTTGTTGACGGC-3′ 5′-TTAGAATTCATCGGCGGTCC-3′ 
forX 5′-AAAAACCACATATGACCGCCAAGC-3′ 5′-TATGAATTCTACTGCGCGGTGG-3′ 
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Table 3-1. Continued. 
 
purA 5′-ATCAAAAACATATGCCGGCACTCG-3′ 5′-CAGGAATTCATGAACGAGTTGATCTGG-3′ 
purB* 5′-AAAAAACATATGACTGCGCCTGC-3′ 5′-AAAGAATTCAGAGGATCGCCCC-3′ 
purC 5′-ATAATAAACATATGAGCGGATTTGTCACC-3′ 5′-AGAGAATTCAGACCCAGCTG-3′ 
purH** 
5′-CCCAAAACCATATGCAACAACGTCG-3′  
(for the wildtype PurH of E. coli) 
5′-TATTTACGCATATGGCCGCCAAGAACC-3′  
(for the truncated PurH of E. coli) 
5′-AAAATCATCATATGTACGACAAGACC-3′ 
(for PurH of S. kaniharaensis) 
5′-TTTTCTCGAGTTAATGGCGGAAGTGG-3′ 
(for the wildtype PurH of E. coli) 
5′-GGGGAATTCTTAATGGCGGAAGTGG-3′ 
(for the truncated PurH of E. coli)  
5′-TTAGAATTCAGTGGAAGAAGTGC-3′ 
(for PurH of S. kaniharaensis) 
* PurB was PCR-amplified from Streptomyces avermitilis. 
** PurH was PCR-amplified from both E. coli and S. kaniharaensis. The C-terminal domain of E. coli PurH was also 
cloned.
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3.2.5 Characterization of Construction of Pyrimidine Ring in Formycin A 
3.2.5.1 Preparation of enzymes and substrates 
The cloning, expression, and purification of ForV, ForR, and ForC were conducted 
as described in Chapter 3.2.4 (Figure 3-3). For ForD, 10% glycerol was added to all buffers 
during purification, and 25 mM potassium phosphate buffer (pH 8.0) was used rather than 
Tris buffer. This is because Tris has been reported to be an inhibitor of the reaction,125 and 
the activity of yeast PurA is extremely sensitive towards chloride concentration.126  
 
 
Figure 3-3.   SDS-PAGE of expressed ForV, ForR, ForC, and ForD. WC: whole cell, 
CFE: cell-free extract, FT: flow-through, E: eluted protein, M: protein 
marker (Pierce unstained protein molecular weight marker).   
 
The genuine Pur enzymes for adenosine biosynthesis were overexpressed for the 
purpose of activity comparison. PurC from S. kaniharaensis and PurH from E. coli and S. 
kaniharaensis were cloned and expressed as described. In addition, the truncated PurH of 
E. coli that only has the C-terminal AICAR formyltransferase domain was cloned and used 
for enzymatic preparation of intermediates. Since the N-terminal His6-tagged PurA from S. 
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kaniharaensis was insoluble, it was cloned as a C-terminal His6-tagged protein in the 
pET24b(+) vector and purified according to the procedure described for ForD. As the 
complete sequence of purB from S. kaniharaensis is not known, PurB from Streptomyces 
avermitilis, which has 85% identity and 92% similarity when compared to the known 
sequence of PurB of S. kaniharaensis, was expressed instead. 
 
 
Figure 3-4.   SDS-PAGE of Pur enzymes involved in adenosine biosynthesis. PurC, 
PurH, and PurA are from S. kaniharaensis, and PurB is from S. avermitilis. 
WC: whole cell, CFE: cell-free extract, FT: flow-through, E: eluted protein, 
M: protein marker (Spectra multicolor broad range protein ladder). 
 
N10-Formyl-tetrahydrofolate (N10-formyl-THF), the donor of formyl group for 
PurH reaction, was anaerobically prepared according to the previously described 
procedure.127 Several pathway intermediates proposed for the biosynthesis of formycin A, 
such as formycin B 5′-phosphate (77), carboxyaminopyrazole ribonucleotide (128), and 5-
aminopyrazole-4-carboxamide ribonucleotide (130), were chemically synthesized by 
Shao-An Wang (manuscript in preparation). 
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3.2.5.2 Activity of ForV and ForR  
The activity of ForV and ForR was assayed according to the procedure described 
for PurC with minor modifications.128 The reaction mixture contained 0.5 mM 
carboxyaminopyrazole ribonucleotide (128), 10 mM L-aspartate, and 2 mM ATP in 50 mM 
Tris buffer (pH 8.0) with 20 mM potassium chloride and 6 mM magnesium chloride. After 
addition of 20 μM ForV and ForR, the reaction mixture was incubated at room temperature 
for 4 hours, and then the enzymes were removed by using YM-10 centrifugal filtration. An 
analytical 4 × 25 mm Dionex CarboPac PA1 anion exchange HPLC column was employed 
using a two-solvent system: solvent A was H2O, and solvent B was 1.5 M ammonium 
acetate in H2O (pH 7.0). The flow rate was 1 mL/min and the detector was set to 260 nm. 
The column was eluted with a two-phase linear gradient: 10 to 20% B in 5 min and then 
20 to 30% B in 15 min. The reaction products eluted at 7.8 min and 24.7 min and were 
collected and lyophilized to dryness for ESI-MS analysis (negative ion mode). The peak at 
7.8 min was identified to be 5-aminopyrazole-4-carboxamide ribonucleotide (130); 
calculated for C9H14O8N4P
– [M – H]–: 337.0555 m/z, found: 337.1 m/z; calculated for 
C9H13O8N4PNa
– [M – 2H + Na]–: 359.0374 m/z, found: 359.0 m/z. Peak at 24.7 min was 
found to be adenosine 5′-diphosphate (ADP); calculated for C10H14O10N5P2– [M – H]–: 
426.0221 m/z, found: 426.0 m/z. 
3.2.5.3 Activity of ForC 
The activity of ForC was assayed following the previously described procedure for 
PurH.129 The reaction mixture contained 33 mM Tris buffer (pH 7.4), 25 mM potassium 
chloride, 5 mM 2-mercaptoethanol, 0.5 mM 5-aminopyrazole-4-carboxamide 
ribonucleotide (130), 1 mM N10-formyl-THF, 50 μM ForC, and 30 μM PurH either from 
E. coli or from S. kaniharaensis. After anaerobic incubation inside the glove box at room 
temperature, the reaction mixture was deproteinized using YM-10 centrifugal filter and 
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analyzed by HPLC using a method similar to that developed for the ForV/ForR reaction. 
The column was eluted with 10% B isocratic for 5 min, 10 to 30% B in 15 min and then 
30% B isocratic for 20 min. The source of PurH did not affect the reaction profile, as the 
HPLC traces were identical. The reaction products eluting at 7.4 min and 14.9 min were 
collected and lyophilized to dryness for ESI-MS analysis (negative ion mode). The peak at 
7.4 min is consistent with 5-formaminopyrazole-4-carboxamide ribonucleotide (131); 
calculated for C10H14O9N4P
– [M – H]–: 365.0504 m/z, found: 365.1 m/z; calculated for 
C10H13O9N4PNa
– [M – 2H + Na]–: 387.0323 m/z, found: 387.0 m/z. Peak at 14.9 min is 
consistent with formycin B 5′-phosphate (77); calculated for C10H12O8N4P– [M – H]–: 
347.0398 m/z, found: 347.0 m/z; calculated for C10H11O8N4PNa
– [M – 2H + Na]–: 369.0218 
m/z, found: 369.0 m/z. The [M – H]– ion of the hydrate form was also detected at 365.1 m/z.  
3.2.5.4 Activity of ForD and ForR 
The ForD/ForR coupled assay was conducted based on a reported assay for PurA 
with minor modifications.126 A solution of 10 μM ForD and 10 μM ForR was incubated 
with 1 mM formycin B 5'-phosphate (77), 2.5 mM L-aspartate, and 0.125 mM guanosine 
triphosphate (GTP) in 1 mL of 25 mM potassium phosphate buffer (pH 8) containing 16 
mM magnesium acetate. To regenerate GTP, 1 mM phosphoenolpyruvate (PEP) and 2 
units pyruvate kinase were also included in the reaction mixture. After incubation for 2 
hours at room temperature, the enzymes were removed by filtering through a YM-10 
centrifugal filter. The reaction was analyzed by HPLC using the same method as the 
ForV/ForR reaction.  
The formation of succinylformycin 5′-phosphate (132) in the reaction mixture of 
ForD alone was not observable under the HPLC condition due to the prolonged retention 
of 132 on the anion exchange column. However, high resolution LC-MS analysis of the 
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reaction confirmed the production of 132. HRMS (ESI, negative ion mode) calculated for 
C14H17N5O11P
– [M – H]–: 462.0668 m/z, found: 462.0658 m/z. The product of the ForD and 
ForR coupled reaction, formycin A 5′-phosphate (78), was eluted at 14.6 min. HRMS (ESI, 
negative ion mode) of 78: calculated for C10H13N5O7P
– [M – H]–: 346.0558 m/z, found: 
346.0556 m/z. The substrate 77 was eluted at 9.5 min under this condition.  
The production of formycin A 5′-phosphate (78) was confirmed by treating it with 
calf intestinal alkaline phosphatase (CIP). Approximately 1 mM of 78 isolated from the 
reaction mixture of ForD and ForR was dissolved in 20 mM Tris buffer (pH 7.9) containing 
50 mM potassium acetate, 10 mM magnesium acetate, and 100 µg/mL bovine serum 
albumin. A total of 100 units of CIP was added, and the reaction mixture was incubated at 
37 °C for 1 hour. After the enzymes were removed by YM-10 centrifugal filtration, the 
reaction mixture was analyzed by HPLC using a Microsorb-MV 100-5 C18 column. A 
two-solvent system of A, 1% ammonium acetate in H2O (pH 5.1), and B, acetonitrile, was 
used for elution with the flow rate set at 1 mL/min, and the UV-detector set to 260 nm. The 
column was eluted with 1% B for 10 min, and then a two-phase linear gradient of 1 to 10% 
B in 20 min and 10 to 35% B in 10 min was applied. While formycin A 5′-phosphate (78) 
was eluted at 5.4 min, formycin A (51) produced from treatment with CIP was eluted at 
19.1 min and co-eluted with the commercially available formycin A standard. The 
collected formycin A was lyophilized to dryness. HRMS (ESI, negative ion mode) 
calculated for C10H12N5O4
– [M – H]–: 266.0895 m/z, found: 266.0893 m/z. 
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3.2.6 Competition Experiment 
The competition experiments were run by mixing both substrates, formycin B 5′-
phosphate (77) and inosine monophosphate (125, IMP) in the reaction, and the ratio of 77 
to 125 was monitored by measuring HPLC peak intensities as a function of fraction of 
reaction. Specifically, the reaction mixture contained 20 mM HEPES (pH 7.7), 1 mM 
magnesium chloride, 0.5 mM GTP, 5 mM L-aspartate, 1 mM PEP, 1 unit pyruvate kinase, 
and 3–5 μM ForD. The concentrations of formycin B 5′-phosphate (77) and IMP (125) 
were varied between 0.1 mM and 1 mM, while keeping the initial concentration ratio of 77 
to 125 below 0.3. Also included in the reaction mixture is 0.2 mM or 0.5 mM of 5-
aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (133, AICAR) which was used as an 
internal standard. The reactions were run at room temperature, and aliquots were taken 
prior to the addition of enzymes and at given time points.  
Each reaction mixture collected at a given time point was analyzed by HPLC using 
a Microsorb-MV 100-5 C18 column. The column was eluted with 1% ammonium acetate 
in H2O (pH 5.1), and washed between injections with a gradient of acetonitrile up to 10%. 
The flow rate was 1 mL/min. The detector was set to 278 nm, which is the absorbance 
maxima of formycin B 5′-phosphate (77) (ε278,77 = 7300 M-1cm-1), to improve the detection 
limit for 77 at low concentrations.110 The relative extinction coefficient of IMP (125) at 
278 nm was estimated to be 2292 M-1cm-1 according to Beer’s Law. The retention time of 
77 and 125 under this HPLC condition was 3.8 min and 4.1 min, respectively. The 
products, succinylformycin 5′-phosphate (132) and succinyladenosine 5′-monophosphate 
(126, SAMP), were eluted at 3.1 min and at 4.5 min, respectively.  
The i-th relative substrate concentration ratio of 77 to 125 (Ri) was measured by 
HPLC peak intensity (hi) and the i-th fraction of reaction (fi) was determined using the 
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internal standard 133, where i = 1 is the first measurement such that R1 is the ratio prior to 
adding enzyme.  
Ri = [77]i / [125]i = (hi,77 · ε278,125) / (hi,125 · ε278,77) 
fi = 1 – {(hi,77 / ε278,77) + (hi,125 · ε278,125)} / {(h1,77 / ε278,77) + (h1,125 · ε278,125)} · (h1,133 / hi,133) 
The ratio of specificity constants (θ1) can then be determined from the residual 
substrate ratio defined implicitly as a function of the fraction of reaction based on the model 
previously established in the study of kinetic isotope effects.130 Fitting of this model to the 
experimental data was done by Dr. Mark W. Ruszczycky using implicit nonlinear least 
squares regression (manuscript in preparation).  
θ1 = ( V / K )77 / ( V / K )125 
= log[(1 – f) · (1/R1 + 1) / (1/Rf + 1)] / log[(1 – f) · (R1 + 1) / (Rf + 1)] 
 
3.2.7 Activity assay of ForS 
The N-terminal His6-tagged ForS was cloned and overexpressed as described in 
Chapter 3.2.5 (see Figure 3-5). The purification was conducted under the same conditions 
except the buffer composition. The lysis buffer was composed of 50 mM N-
tris(hydroxymethyl)-methyl-2-aminoethanesulfonic acid (TES) (pH 7.5) containing 10 
mM magnesium chloride. For Ni-NTA purification, the slurry was washed with the lysis 
buffer containing 20 mM imidazole and the protein was eluted with the lysis buffer 
containing 250 mM imidazole. The eluted protein was diluted prior to dialysis in order to 
prevent precipitation. The pooled protein was dialyzed against 1 L of 50 mM TES buffer 
(pH 7.5) containing 20% glycerol three times before storage at –80 °C. 
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Figure 3-5.   SDS-PAGE of ForS (expected molecular weight: 38.7 kDa). WC: whole 
cell, CFE: cell-free extract, W: wash, E: eluted protein, M: protein marker 
(Spectra multicolor broad range protein ladder).  
 
To test the activity of ForS, a reaction mixture containing 1.25 mM PRPP (74), 5 
mM of putative substrate in 50 mM TES buffer (pH 7.5) was incubated with 10 μM ForS 
at room temperature. The substrates tested were L-glutamate, D-glutamate, L-aspartate, α-
ketoglutaric acid, (4R)-4-hydroxy-L-glutamate, 4-hydroxy-2-ketoglutaric acid, and 3,5-
pyrazoledicarboxylic acid. All compounds are commercially available. The enzyme 
activity was assayed either by pyrophosphate assay or by LCMS. In order to quantitate 
pyrophosphate released upon coupling between PRPP (74) and substrate, the reaction 
mixture was quenched after 2 hours by boiling. After collecting supernatant by 
centrifugation, the concentration of pyrophosphate in 50 times diluted samples was 
determined according to the previously described procedure.131 For LCMS analysis, the 
reaction mixture was deproteinized by using YM-10 centrifugal filtration and submitted 
for LCMS. 
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3.2.8 PCR-based Screening of S. antibioticus  
The genomic DNA of S. antibioticus was extracted from the culture in TSB media 
grown at 30 °C for 2 days according to the reported procedure.132 The extracted DNA was 
screened by PCR to identify the homologs of hisG and hisA using specific primers. Primers 
were designed based on known conserved sequences of hisG and hisA involved in the 
histidine biosynthesis in various Streptomyces species: 4 forward (hisG_1F to hisG_4F) 
and 3 reverse primers (hisG_1R to hisG_3R) for hisG, and 3 forward (hisA_1F to hisA_3F) 
and 2 reverse primers (hisA_1R and hisA_2R) for hisA. 
hisG_1F: 5′-ATCGCCGTCCCCAACAAGGG-3′  
hisG_2F: 5′-ATGCTSCATGAGGCSGGCTACC-3′  
hisG_3F: 5′-AACGAGGTSGAGTTCTTCTACC-3′  
hisG_4F: 5′-CTSGACATCGGCATCACSGG-3′  
hisG_1R: 5′-GCAGTCGTAGTCCATCATCACG-3′  
hisG_2R: 5′-ACCCAGCCCTCGTKGTGSAGC-3′  
hisG_3R: 5′-TCGTCCATGACCCGCTGSGC-3′  
hisA_1F: 5′-CGCCGTCGACGTCCGYGACG-3′  
hisA_2F: 5′-CTSGTSCACGGCGWGTCCGG-3′  
hisA_3F: 5′-GACCTSGACGCSGCSTTCGG-3′  
hisA_1R: 5′-TGCCGTCCTTGGCGATGTCGG-3′ 
hisA_2R: 5′-TGAACGCCTTSGCGTASAGSGCC-3′ 
 
After PCR using the above primers and the genomic DNA as a template, the PCR 
fragments were cloned into the pCR-Blunt vector and sequenced. A total of 20 samples for 
hisG and 34 samples for hisA were sequenced. Only one hisG and one hisA were found. 
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3.2.9 Activity Assay of the Reductase Involved in the Biosynthesis of Coformycin 
The gene orf -2 encoded upsteam of the formycin A biosynthetic gene cluster was 
cloned and expressed as an N-terminal His6-tagged protein and purified as described in 
Chapter 3.2.4 except for the buffer composition. The lysis buffer was 50 mM HEPES buffer 
(pH 8.0). The wash and elution buffers contained 25 mM or 250 mM imidazole, 
respectively. The purified protein was dialyzed against 50 mM HEPES (pH 8.0) containing 
10% glycerol.  
The activity of ORF -2 was tested by conducting a reverse reaction, which is the 
oxidation of 2′-deoxycoformycin (109) to 8-ketodeoxycoformycin (120). Specifically, 0.4 
μM ORF -2 was incubated with 0.5 mM 109 in 50 mM HEPES buffer (pH 8.0) in the 
presence of 1 mM NADP+ for 2 hours at room temperature. The UV absorbance at 340 nm 
was monitored to follow the production of NADPH. To quench the reaction, 4 volumes of 
ethanol was added and incubated at 4 °C for 10 min. The supernatant was collected by 
centrifugation and dried in a speed vacuum concentrator. The sample was re-dissolved in 
water and analyzed by HPLC using a Microsorb-MV 100-5 C18 column. The column was 
eluted with 2% acetonitrile in 50 mM ammonium acetate. 2′-Deoxycoformycin (109) was 
typically eluted at 19.3 min under these conditions. The peak at 16.1 min was isolated and 
analyzed by ESI-MS in positive ion mode. Its molecular weight is consistent with that of 
the oxidized product 8-ketodeoxycoformycin (120); calculated for C11H15O4N4Na
+ [M + 
Na]+: 289.0913 m/z, observed: 289.1 m/z.  
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3.3 RESULTS AND DISCUSSION 
 
3.3.1 Identification of the Putative Biosynthetic Gene Cluster of Formycin A 
As the genomic information of a formycin-producing strain is not available, the 
genome of S. kaniharaensis was sequenced in order to identify the biosynthetic pathway 
of formycin A. Over 3000 contiguous sequences (contigs) with an average size of 2641 bp 
were obtained from genome sequencing. Although the size of the contigs was relatively 
short for thorough inspection of the biosynthetic gene cluster, the preliminary analysis 
revealed that two homologous copies of the purA, purB, purC, and purH genes reside in S. 
kaniharaensis. The enzymes encoded by those pur genes (PurA, PurB, PurC, and PurH) 
are reported to catalyze the conversion of carboxyaminoimidazole ribonucleotide (121, 
CAIR) to AMP (127) during the later stage of adenosine biosynthesis (Figure 3-6).133,134 
The second set of pur homologous genes exhibited relatively low similarity compared to 
the highly conserved pur genes involved in adenosine biosynthesis, which allowed the 
distinction between these two sets of genes (see Table 3-3). Given the considerable 
structural resemblance of formycin A (51) and adenosine (53), the presence of a second set 
of pur genes was indicative of an analogous biosynthetic pathway underlying assembly of 
the pyrazolopyrimidine nucleobase in formycin A. 
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Figure 3-6.   The later steps in the biosynthesis of adenosine (53).  
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Enzymes involved in the production of bacterial secondary metabolites are 
commonly encoded by chromosomally clustered genes (i.e., biosynthetic gene clusters).135 
In an effort to discover the entire gene cluster for formycin A, a cosmid library was 
constructed from the genomic DNA of S. kaniharaensis and screened by PCR. The primers 
used for PCR were specifically designed based on the sequences of the second copy of 
purA, purC, and purH genes. A single cosmid, designated K24C, was found to harbor all 
of the purA, purC, and purH homologous genes, while the K5B cosmid was found to 
contain the purC homologous gene. The cosmid K24C was fully sequenced by primer 
walking, and it was found that the size of the K24C cosmid is around 41 kbp containing 35 
ORFs defined within the cosmid. The functional annotation based on bioinformatics 
analysis using a BLAST search permitted identification of the biosynthetic gene cluster of 
formycin A in the K24C cosmid (Figure 3-7). Spanning approximately 30 kbp, the putative 
formycin A gene cluster contains 24 ORFs. The complete functional annotation of the 
individual gene products in the putative gene cluster are shown in Table 3-2. The second 
copy of homologous purA (forD), purB (forR), purC (forV), and purH (forC) found in the 
gene cluster exhibits 50% sequence similarities with the pur genes involved in the 
biosynthesis of adenosine in S. kaniharaensis (Table 3-3). On the contrary, the genuine pur 
genes for the essential primary pathway are highly conserved in all Streptomyces species 
showing 90% sequence similarities. The differences between these sets of genes strongly 
suggest that the second set of genes is involved in the secondary metabolism and may have 
evolved from the primary biosynthetic pathway. It should be also noted that significant 
similarities were found between the genes in the identified for gene cluster and those 
encoded in uncharacterized gene clusters in Streptomyces resistomycificus136 and 
Salinispora arenicola,137 although whether the latter two strains produce formycin A or a 
derivative thereof is not known.    
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Figure 3-7.   Biosynthetic gene cluster of formycin A in S. kaniharaensis. The putative 
functions of each gene product are color-coded, and the ORFs considered 
outside the gene cluster are shown in gray. The complete functional 
annotation is listed in Table 3-2.  
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Table 3-2.   Functional annotation of individual gene product in formycin A biosynthetic 
gene cluster. 
Gene 
Size 
(aa) 
Protein Homolog [Origin] Accession 
Identity/ 
Similarity 
(%/%) 
for1 453 GntR family transcriptional regulator 
[Streptomyces resistomycificus] 
WP_037802186.1 
 
72/79 
for2 336 Hypothetical protein [Streptomyces 
resistomycificus] 
WP_030038112.1 34/47 
for3 415 Major facilitator superfamily (MFS) 
transporter [Streptomyces 
resistomycificus] 
MFS transporter [Salinispora 
arenicola] 
WP_053190963.1 
WP_012180823.1 
65/78 
49/61 
forA 450 Xenobiotic compound 
monooxygenase A subunit 
[Salinispora arenicola] 
WP_012180830.1 79/88 
forB 343 Hypothetical protein [Streptomyces 
resistomycificus] 
Putative monooxygenase [Salinispora 
arenicola] 
WP_051869545.1 
ABV96521.1 
60/70 
57/67 
forC 197 Phosphoribosylaminoimidazolecarbox
amide formyltransferase 
[Streptomyces resistomycificus] 
Phosphoribosylaminoimidazolecarbox
amide formyltransferase [Salinispora 
arenicola] 
WP_030038113.1 
WP_028673470.1 
76/85 
65/72 
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Table 3-2.   Continued. 
 
forD 424 Adenylosuccinate synthetase 
[Streptomyces resistomycificus] 
Adenylosuccinate synthetase 
[Salinispora arenicola] 
WP_030038114.1 
WP_029537068.1 
73/84 
64/77 
forE 334 2-hydroxyacid dehydrogenase, partial 
[Streptomyces resistomycificus] 
D-Isomer specific 2-hydroxyacid 
dehydrogenase [Salinispora 
arenicola] 
WP_030038115.1 
WP_012180805.1 
84/91 
70/81 
forF 211 Hypothetical protein [Streptomyces 
resistomycificus] 
WP_051869535.1 69/75 
forG 424 Membrane protein [Streptomyces 
resistomycificus] 
Class III aminotransferase 
[Salinispora arenicola] 
WP_030038117.1 
WP_012180807.1 
83/91 
68/77 
forH 675 Methionine–tRNA ligase, partial 
[Streptomyces resistomycificus] 
Methionine–tRNA ligase [Salinispora 
arenicola] 
WP_051869537.1 
WP_029537071.1 
67/75 
61/73 
forI 441 L-Lysine 6-monooxygenase 
[Streptomyces resistomycificus] 
L-Lysine 6-monooxygenase 
[Salinispora arenicola] 
WP_030038120.1 
WP_028675079.1 
72/84 
63/78 
forJ 385 Saccharopine dehydrogenase 
[Streptomyces resistomycificus] 
Saccharopine dehydrogenase 
[Salinispora arenicola] 
WP_053190969.1 
WP_028676437.1 
65/76 
58/70 
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Table 3-2.   Continued. 
 
forK 421 Phosphoribosylglycinamide synthetase 
[Streptomyces resistomycificus] 
Phosphoribosylglycinamide synthetase 
[Salinispora arenicola] 
WP_030038122.1 
WP_012180811.1 
81/88 
69/80 
forL 128 Hypothetical protein   
forM 646 Hypothetical protein [Streptomyces 
resistomycificus] 
Peptidase S9 [Salinispora arenicola] 
WP_053190961.1 
WP_028678644.1 
58/68 
53/65 
forN 191 NUDIX hydrolase [Streptomyces] 
NUDIX hydrolase [Salinispora 
arenicola] 
WP_030290725.1 
WP_016815025.1 
82/87 
60/71 
forO 397 Amidohydrolase [Streptomyces 
resistomycificus] 
Amidohydrolase [Salinispora 
arenicola] 
WP_053190965.1 
WP_012180815.1 
83/89 
70/79 
forP 375 Hypothetical protein [Streptomyces 
resistomycificus] 
FAD-dependent oxidoreductase 
[Salinispora arenicola] 
WP_030038132.1 
WP_012180814.1 
73/79 
59/67 
forQ 539 Fumarate reductase [Streptomyces 
resistomycificus] 
Fumarate reductase [Salinispora 
arenicola] 
WP_030038133.1 
WP_038842037.1 
77/84 
62/71 
forR 475 Adenylosuccinate lyase [Streptomyces 
resistomycificus] 
WP_030038134.1 82/89 
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Table 3-2.   Continued. 
 
forS 342 β-Ribofuranosylaminobenzene 5′-
phosphate synthase [Streptomyces 
resistomycificus] 
β-Ribofuranosylaminobenzene 5′-
phosphate synthase [Salinispora 
arenicola] 
WP_030038135.1 
WP_012180817.1 
78/84 
67/75 
forT 409 Phthalate 4,5-dioxygenase 
[Streptomyces resistomycificus] 
Phthalate 4,5-dioxygenase 
[Salinispora arenicola] 
WP_053190967.1 
WP_028677418.1 
87/92 
75/85 
forU 186 FMN reductase [Streptomyces] WP_030247495.1 75/85 
forV 334 SAICAR synthetase [Streptomyces 
resistomycificus] 
SAICAR synthetase [Salinispora 
arenicola] 
WP_051869569.1 
WP_028673475.1 
65/75 
59/70 
forW 937 Oxidoreductase [Mycobacterium] WP_024454584.1 62/72 
forX 296 Ribokinase [Salinispora arenicola] 
Ribokinase [Streptomyces 
resistomycificus] 
WP_029537066.1 
WP_051869540.1 
57/66 
55/67 
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Table 3-3.   Sequence similarity between two sets of Pur-like enzymes. 
 Identity/Similarity (%/%) 
S. 
kaniharaensis 
S. coelicolor S. griseus S. avermitilis S. scabiei 
 PurA (427 aa) PurA (427 aa) PurA (427 aa) PurA (427 aa) 
PurA (427 aa) 88/94 88/95 86/94 87/93 
ForD (423 aa) 40/56 39/56 40/57 40/57 
 PurC (299 aa) PurC (304 aa) PurC (299 aa) PurC (299 aa) 
PurC (299 aa) 75/87 75/84 76/87 76/87 
ForV (333 aa) 31/41 28/43 30/40 29/42 
 PurH (523 aa) PurH (517 aa) PurH (527 aa) PurH (520 aa) 
PurH (502 aa) 83/89 82/87 81/88 82/89 
ForC (196 aa) 40/53 38/51 38/53 39/53 
 PurB (480 aa) PurB (480 aa) PurB (479 aa) PurB (480 aa) 
PurB* (336 aa) 85/92 85/93 85/92 85/92 
ForR (474 aa) 74/85 74/85 74/85 75/85 
* Only partial sequence (336 aa) is known. 
 
ORFs flanked by the putative gene cluster at both ends (For1, 2, 3 and ORFs 1, 2, 
3, 4 in Figure 3-7) encode a transcriptional regulator, a transporter, enzymes involved in 
primary metabolism, or proteins of unknown function, and are likely the boundaries of the 
cluster. E. coli transformed with the K24C cosmid showed reduced lifespans, and the 
cosmid isolated after passaging the cells was found to lose part of the putative gene cluster. 
Heterologous expression of the biosynthetic gene cluster was hindered due to the partial 
loss of the gene cluster. However, those observations may suggest that the metabolite 
produced by the enzymes encoded in the putative gene cluster are toxic to the host bacteria 
E. coli.   
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3.3.2 Formation of Pyrazolopyrimidine Nucleobase 
As discussed in the previous section, the presence of pur-like genes including forD, 
forR, forV, and forC implied that the later steps of formycin A biosynthesis are analogous 
to those of the adenosine biosynthetic pathway (Figure 3-8). Each enzyme was 
overexpressed in E. coli, and three pathway intermediates were synthesized. The enzyme 
activities were assayed to test the proposed pathway for the assembly of pyrimidine ring of 
formycin A. 
ForV and ForR are proposed to catalyze the conversion of carboxylic acid 128 to 
amide 130. The consumption of carboxyaminopyrazole ribonucleotide (128) was observed 
by HPLC when 0.5 mM 128 was incubated with 20 μM ForV in the presence of 10 mM L-
aspartate and 2 mM ATP (Figure 3-9, traces 1 and 2). While no peak corresponding to 129 
was detected due to the prolonged retention of 129 in the column under this condition, the 
formation of ADP indicated reaction progress. The addition of 20 μM ForR to the reaction 
mixture resulted in a new peak at the retention time of 7.8 min (Figure 3-9, trace 3), which 
was identified to be 5-aminopyrazole-4-carboxamide ribonucleotide (130) based on ESI-
MS analysis (calculated for C9H14O8N4P
– [M – H]–: 337.0555 m/z, found: 337.1 m/z). The 
product also co-eluted with a chemically synthesized standard 130. These results showed 
that the amide moiety of 130 is introduced by ForV and ForR using L-aspartate as the amino 
donor.  
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Figure 3-8.   The later steps of proposed pathway for formycin A (51) are analogous to 
those in the primary adenosine biosynthetic pathway. The structure of 5-
aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (133, AICAR) used as 
a HPLC internal standard in competition experiment (see Chapter 3.3.3) is 
shown in the box. 
  
 115 
 
Figure 3-9.   HPLC traces showing the reactions catalyzed by ForV and ForR. Trace 1 is 
the reaction mixture of 128, L-aspartate, and ATP analyzed before addition 
of enzymes. Trace 2 is the same reaction mixture as trace 1 incubated with 
ForV for 4 h. Trace 3 is the same reaction mixture as trace 1 incubated with 
ForV and ForR together for 4 h. It was noted that AMP was formed in the 
reaction mixture for unknown reason.  
    
The bacterial PurH involved in the biosynthesis of adenosine is a bifunctional 
enzyme that consists of the N-terminal IMP cyclohydrolase domain and the C-terminal 
AICAR formyltransferase domain.129,134 It should be pointed out that ForC in the formycin 
A gene cluster is less than half of PurH in size, and has homology only to the N-terminal 
domain of PurH. As the formyltransferase domain is missing in ForC, it did not react with 
5-aminopyrazole-4-carboxamide ribonucleotide (130). Instead, PurH of S. kaniharaensis 
exhibited the formyltransferase activity when 30 μM PurH was anaerobically incubated 
with 0.5 mM 130 and 1 mM N10-formyl-THF (Figure 3-10, traces 1 and 2). The isolated 
product eluting at 7.4 min was found to be 5-formaminopyrazole-4-carboxamide 
ribonucleotide (131), which gave signals at 365.1 and 387.0 m/z corresponding to [M – H]– 
 116 
and [M – 2H + Na]– ions of 131 in ESI-MS. The reaction of E. coli PurH with 130 also 
produced the formylated compound 131, rather than the cyclized product 77. This was in 
contrast with the formation of inosine monophosphate (125, IMP) from the reaction of E. 
coli PurH with 5-aminoimidazole-4-carboxamide ribonucleotide (123) (see Figure 3-6). It 
is noteworthy that E. coli PurH does not catalyze the cyclization to form formycin B 5′-
phosphate (77), which alludes to the specificity of Pur enzymes towards two close 
structural isomers. It is not clear as of now whether the formyl transfer reaction is catalyzed 
by an enzyme encoded in the putative gene cluster. When both 50 μM ForC and 30 μM 
PurH were included in the anaerobic incubation, ForC was capable of catalyzing the 
cyclization of the formylated intermediate 131. The product, formycin B 5′-phosphate (77), 
was detected as [M – H]– and [M – 2H + Na]– at 347.0 and 369.0 m/z, respectively. 
  
 
Figure 3-10.   HPLC traces showing the reaction of PurH and ForC. Trace 1 is the 
reaction mixture containing 130 and N10-formyl-THF before addition of 
enzymes. Trace 2 is the same reaction mixture as trace 1 incubated with 
PurH of S. kaniharaensis for 1 h. Trace 3 is the same reaction mixture as 
trace 1 incubated with PurH of S. kaniharaensis and ForC for 1 h. All 
reactions were conducted anaerobically inside glove box.  
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Formycin A 5′-phosphate (78) is proposed to be biosynthesized from formycin B 
5′-phosphate (77) by ForD and ForR, which is consistent with an early experiment showing 
77 as a likely precursor to formycin A (see Figure 3-8).66 The consumption of formycin B 
5′-phosphate (77) was observed upon the addition of 10 μM ForD into the reaction mixture 
of 1 mM 77, 2.5 mM L-aspartate, and 0.125 mM GTP (Figure 3-11, traces 1 and 2). The 
formation of succinylformycin 5′-phosphate (132) was demonstrated by high resolution 
LC-MS analysis (calculated for C14H17N5O11P
– [M – H]–: 462.0668 m/z, found: 462.0658 
m/z), which was also observable by HPLC using a Microsorb-MV 100-5 C18 column (see 
Figure 3-12). The coupling reaction of 10 μM ForD and 10 μM ForR produced a new peak 
with the retention time of 14.6 min (Figure 3-11, trace 3). The new product was identified 
to be formycin A 5′-phosphate (78) by ESI-MS analysis, which gave a signal at 346.0556 
m/z corresponding to [M – H]– ion of 78 (calculated for C10H13N5O7P– [M – H]–: 346.0558 
m/z). 
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Figure 3-11.  HPLC traces showing the reactions catalyzed by ForD and ForR. Trace 1 is 
the reaction mixture containing 77, L-aspartate, and GTP, which was 
analyzed before addition of enzymes. Trace 2 is the same reaction mixture 
as trace 1 incubated with ForD for 2 h. Trace 3 is the same reaction mixture 
as trace 1 incubated with ForD and ForR together for 2 h. Trace 4 is the 
reaction product 78 isolated from trace 3. Trace 5 is the incubation of 78 
with CIP for 1 h that resulted in the formation of 51. Trace 6 is the injection 
of standard formycin A, which shows that the retention time of 51 is the 
same as that of formycin A. Traces 1 to 3 were analyzed by HPLC anion 
exchange column, whereas traces 4 to 6 were analyzed by C18 column (see 
Chapter 3.2.5.4 for detailed HPLC methods).   
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The identity of the ForD/ForR reaction product as formycin A 5′-phosphate (78) 
was further confirmed by hydrolyzing the phosphate moiety. Incubation of the isolated 
reaction product with 100 units of CIP resulted in a new compound that co-eluted with the 
commercial standard of formycin A (51) (see Figure 3-11, traces 5 and 6). The mass signal 
at 266.0893 m/z observed by high resolution ESI-MS was consistent with [M – H]– ion of 
formycin A (calculated for C10H12N5O4
– [M – H]–: 266.0895 m/z). These results 
demonstrated the conversion of formycin B 5′-phosphate (77) to formycin A 5′-phosphate 
(78) by ForD and ForR as proposed. Taken together, the pyrimidine ring in formycin A is 
assembled by catalysis of Pur-like enzymes including ForV, ForR, ForC, and ForD in an 
analogous pathway to adenosine biosynthesis, which supports the hypothesis that the 
biosynthesis of formycin A is carried out by enzymes encoded in the identified biosynthetic 
gene cluster (see Figure 3-8). 
 
 
3.3.3 Specificity of ForD  
The reactions catalyzed by Pur-like enzymes during construction of the 
pyrozolopyrimidine nucleobase in formycin A are likely to follow similar reaction 
mechanisms compared to the corresponding reactions in the adenosine biosynthetic 
pathway. This prompted the question as to whether the homologous enzymes exhibit 
specificity/promiscuity toward putative intermediates in formycin A and adenosine 
pathways.  
In order to examine the substrate specificity, the reaction of ForD and PurA with 
either formycin B 5′-phosphate (77) or IMP (125) as a substrate were investigated. It was 
shown that ForD can accept both 77 and 125 as a substrate (Figure 3-12). The condensation 
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reaction between 77 and L-aspartate by ForD resulted in the formation of succinylformycin 
5′-phosphate (132) (traces 1 to 3). Likewise, the production of succinyladenosine 5′-
monophosphate (126, SAMP) was observed from the ForD reaction of 125 and L-aspartate 
(traces 4 to 6). On the other hand, PurA was shown to strictly recognize 125 and did not 
react with 77 (Figure 3-13). 
 
 
 
Figure 3-12.  HPLC traces of ForD reactions. Traces 1 to 3 are the ForD reaction mixture 
with 77 as a substrate. Trace 1 was measured before adding enzymes, and 
traces 2 and 3 were measured after 10 min and 25 min upon addition of 
ForD. Traces 4 to 6 are the ForD reaction mixture with 125. Trace 4 was 
measured before adding enzymes, and traces 5 and 6 were measured after 5 
min and 25 min upon addition of ForD. The peak at 2.8 min is an unknown 
contaminant from enzyme preparation. 
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Figure 3-13.  HPLC traces of PurA reactions. Trace 1 is the reaction mixture with 125 
before adding enzyme, and trace 2 is the same reaction mixture incubated 
with PurA for 10 min. Trace 3 is the co-injection of trace 2 and 125. Traces 
4 to 6 are the PurA reaction mixture with 77. Trace 4 was measured before 
adding enzymes, and traces 5 and 6 were measured after 10 min and 60 min 
upon addition of ForD. AICAR (133) was included as an internal standard. 
 
 
While ForD was able to process both substrates, it appeared that ForD indeed 
prefers formycin B 5′-phosphate (77) over IMP (125), which is consistent with 77 being 
the biosynthetically relevant substrate for ForD (Figure 3-14). A more quantitative analysis 
was provided by a competition experiment in which the reaction progress was monitored 
in the presence of both substrates. The samples were taken prior to addition of ForD and at 
given times, and the concentration ratio of 77 to 125 (Ri) was determined based on the 
HPLC peak integration and extinction coefficients. The fraction of reaction (fi) was 
calculated by taking relative integration of each peak to the area of internal standard 
AICAR (133, see Figure 3-8 for the structure). The substrate enrichment was observed as 
one of the substrates (i.e., formycin B 5′-phosphate (77)) was consumed faster over the 
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other (Figure 3-15). The specificity constant ratio (θ1) was then found to be 8.65 ± 0.58 by 
averaging estimates obtained from implicit nonlinear least squares regression over five 
separate trials. These results indicate that ForD preferentially recognizes and processes 77 
over 125 despite their very similar structures, which are in a good agreement with the 
functional assignment of Pur-like enzymes to the biosynthesis of formycin A.  
 
 
 
Figure 3-14.  Competition experiment. Trace 1 is the reaction mixture with 77 and 125 
measured before adding ForD. Traces 2 and 3 were measured after 10 min 
and 20 min upon addition of ForD. AICAR (133) was included as an 
internal standard. 
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Figure 3-15.  The representative plot of substrate concentration ratio of 77 to 125 (Ri) as a 
function of fraction of reaction (fi). The solid black circles are the observed 
experimental data. The white circles and black line denote the corresponding 
fitted data points. The gray lines are the calculated curves of R versus f at 
different fixed specificity constant ratios (θ1). The broken line denotes the 
asymptote for θ1 → ∞. 
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3.3.4 Proposed Biosynthesis of Formycin A 
As discussed in Chapter 3.3.2, the later steps of formycin A biosynthesis are 
expected to follow a pathway analogous to that of adenosine biogenesis. The 
biotransformation from carboxyaminopyrazole ribonucleotide (128) to formycin A 5′-
phosphate (78) in formycin A biosynthesis was shown to be catalyzed by a series of Pur-
like enzymes—ForV, ForR, ForC, and ForD (see Figure 3-8). However, the early pathway 
leading to the formation of 128 seems to be distinct from the biosynthesis of CAIR (121) 
and remains speculative at the present time. Nevertheless, the construction of a C-
glycosidic bond between PRPP (74) and a glutamate derivative is proposed to take place 
at the early stage considering the asymmetrical incorporation pattern of L-glutamate (75) 
as demonstrated by feeding experiments, because the isotope labeling in the final product 
would be scrambled otherwise (see Chapter 1.2.3).69,70 L-Glutamate (75) is expected to be 
incorporated as a single unit, which also suggests that the N7 nitrogen of formycin A is 
likely derived from the α-amino group of L-glutamate (75). The original proposal in which 
the N7 nitrogen originates from the ε-amino group of L-lysine (76) (see Figure 1-20) is 
likely due to in vivo catabolism of 76 to 75.138  
Interestingly, the gene product of forS exhibits 31% sequence identity and 47% 
similarity to MJ1427, a β-ribofuranosylaminobenzene 5′-phosphate synthase found in 
Methanocaldococcus jannaschii. MJ1427 catalyzes the decarboxylative coupling of PRPP 
(74) with 4-hydroxybenzoic acid (134) during the first step of methanopterin biosynthesis 
(Figure 3-16).139,140 The considerable homology of ForS to MJ1427 implied that a similar 
coupling reaction of PRPP (74) with L-glutamate (75) or a derivative thereof catalyzed by 
ForS could result in the C-glycosidic linkage.  
 
 
 125 
 
Figure 3-16.  Formation of C-glycosidic bond by MJ1427 in M. jannaschii. 
 
The forS gene was heterologously overexpressed as an N-terminal His6-tagged 
protein in E. coli. The activity of ForS was assayed either by quantitating pyrophosphate 
released upon the formation of the C-glycosidic bond or by LCMS analysis. The substrates 
tested using the pyrophosphate assay included L-glutamate, D-glutamate, and α-
ketoglutaric acid; however, none of them showed any activity (Figure 3-17). Likewise, the 
analysis by LCMS showed that the incubation of ForS with (4R)-4-hydroxy-L-glutamate 
(136) or 4-hydroxy-2-ketoglutaric acid (137) did not result in a product (Figure 3-18). 
These observations implied that the substrate for ForS has to be activated prior to 
nucleophilic addition to PRPP (74). L-Glutamate (75) itself does not have any functionality 
to stabilize the anionic character required for nucleophilic attack. On the contrary, the 
substrate of MJ1427 (134) has the aromatic ring with a para substituent that promotes the 
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decarboxylative coupling in a similar mechanism to the aromatic substitution. It should be 
mentioned that there was no reaction when 3,5-pyrazoledicarboxylic acid (138) was 
incubated with ForS, which suggested formation of the C-glycosidic linkage prior to 
assembly of the pyrazolopyrimidine moiety. 
 
 
 
Figure 3-17.  Activity assay for the formation of C-glycosidic bond by ForS.  
 
 
 
Figure 3-18.  Structures of L-glutamate (75) and its derivatives tested in ForS assay.    
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The early part of the biosynthetic pathway for formycin A is proposed based on 
functional annotation of the enzymes found in the gene cluster, as shown in Figure 3-19 
and Figure 3-20. Although the substrate for ForS has not been identified, the C-glycosydic 
linkage in formycin A seems to be constructed in a reaction catalyzed by ForS that 
facilitates nucleophilic addition of a derivative of L-glutamate to PRPP (74). In this respect, 
β,γ-unsaturated glutamate (139) or β-keto glutamate (152) is proposed as the potential 
substrate for ForS. ForQ is a homolog of succinate dehydrogenase, which may catalyze the 
dehydrogenation of 75 preceding the C–C bond formation (see Figure 3-19). The formation 
of a C-glycosydic linkage between 139 and 74 is then catalyzed by ForS, facilitated by the 
anionic character developed upon α-deprotonation and delocalized over the conjugating 
system. Subsequent dihydroxylation and oxidation by ForT and ForE, respectively, can 
produce the intermediate 142. The alternative pathway proposes β-hydroxylation of 75 by 
ForA or ForB to be the first step, followed by the oxidation of hydroxyl group by ForE to 
form β-keto glutamate (152) (Figure 3-20). The decarboxylative coupling by ForS may 
generate 153. Then hydroxylation of 153 by ForA or ForB may lead to the intermediate 
154, which is readily tautomerized to 142.  
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Figure 3-19.  Proposed biosynthetic pathway for the formation of putative intermediate, 
carboxyaminopyrazole ribonucleotide (128). 
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Figure 3-20.  Alternative pathway for the formation of 142. 
 
Introduction of the ε-nitrogen of L-lysine (76) into the pyrazole ring is hypothesized 
to be catalyzed by a series of enzymes such as ForH, ForI, and ForJ, which appear to be a 
homolog of methionine–tRNA ligase, L-lysine 6-monooxygenase, and saccharopine 
dehydrogenase, respectively. N-Hydroxylysine (143) generated by ForI can be ligated with 
142 by ForH to form 144. Such an association of methionine–tRNA ligase with L-lysine 6-
monooxygenase can be found in many bacteria producing peptide-derived antibiotics.141 
The following oxidation and hydrolysis catalyzed by ForJ may generate the intermediate 
146 with the hydrazine moiety, which then be cyclized by ForK to afford 147. The 
subsequent oxidation catalyzed by ForP or ForW, transamination by ForG, and iminium 
ion formation by ForP or ForW are proposed to form carboxyaminopyrazole ribonucleotide 
(128). 
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3.3.5 Biosynthesis of Coformycin 
The formycin-producing bacteria also produce coformycin (108), a nucleoside 
antibiotic with a seven-membered heterocycle.52,103 Coformycin (108) and its deoxyribose 
counterpart 2′-deoxycoformycin (109) are known to be derived from adenine nucleotide, 
and the expansion of the purine ring is from the insertion of one carbon from ribose (see 
Figure 3-2).118,119 The early steps are proposed to be similar to histidine biosynthesis (111, 
112 → 116).121 Thus, the genome of S. antibioticus, which produces 109, was searched for 
homologous genes. The PCR-based screening was conducted using primers specifically 
designed based on the known conserved sequences of hisG and hisA in Streptomyces 
species, of which gene products catalyze the 1st and 4th step of histidine biosynthesis. The 
screening identified only one kind of hisG and hisA in S. antibioticus, supporting the idea 
that the biosynthesis of 108 and 109 utilizes the intermediate 116 from the histidine 
pathway. 
The genes involved in the production of coformycin are expected to be located in 
close proximity to the formycin A gene cluster given their strongly associated physical 
properties. In the course of investigating the biosynthetic gene cluster for formycin A in S. 
kaniharaensis, it was noticed that one upstream gene adjacent to the gene cluster encodes 
an NAD(P)H-dependent reductase (orf -2 in Figure 3-4). The early study using partially 
purified cell-free extract of S. antibioticus has shown that the reduction of 8-keto 
compounds (119 and 120) is a requisite step in the biosynthesis of coformycin, and the 
reduction reaction requires NADPH as the hydride donor.120 The presence of an NAD(P)H-
dependent reductase in the vicinity of formycin A gene cluster suggested that it could be 
responsible for the final reduction reaction to generate coformycin.  
The reductase was expressed and purified as an N-terminal His6-tagged protein, and 
the activity was assayed in the reverse reaction using the commercially available 2′-
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deoxycoformycin (109) as a substrate. When 0.5 mM 109 was incubated with 0.4 μM 
enzyme in the presence of 1 mM NADP+, the increase in the UV absorbance at 340 nm 
was observed indicating the production of NADPH concomitant with the oxidation of 109 
(Figure 3-21). The reaction mixture containing NAD+ instead of NADP+ did not result in 
a significant increase in UV absorbance, consistent with the previous study.120 The product 
was isolated by HPLC (Figure 3-22) and analyzed by ESI-MS (positive ion mode), which 
gave a clear signal at 289.1 m/z. This corresponded to the [M + Na]+ ion of 8-
ketodeoxycoformycin (120), suggesting that ORF -2 is involved in the reduction of 8-keto 
compounds (119 and 120). It is unknown whether the enzyme exhibits a comparable 
activity toward phosphorylated compounds (118). Further kinetic analysis is required to 
establish the newly identified ORF -2 as the pathway-specific reductase. While 
preliminary, these results support the identification of the reductase for the last step of 
coformycin biosynthesis, which corroborates the proposed pathway through the 
intermediary of 8-ketocoformycin (119).  
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Figure 3-21.  Activity assay of ORF -2. The enzyme was added at around 60 sec. The 
black line denotes the reaction with NADP+, and the dotted line denotes the 
reaction with NAD+ instead of NADP+. The dashed line corresponds to the 
reaction containing neither NADP+ nor NAD+, and the dashed-dotted line 
corresponds to the reaction without substrate 109.  
 
Figure 3-22.  HPLC traces showing the reaction of ORF -2. Trace 1 is the reaction 
mixture containing 0.5 mM 109 and 1 mM NADP+ before adding ORF -2, 
and trace 2 is the same reaction mixture as trace 1 incubated with 0.4 μM 
ORF -2 for 2 h.     
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3.4 CONCLUSION 
Reported here is an investigation of the biosynthesis of formycin A (51) by 
sequencing the genome of S. kaniharaensis. The genomic analysis revealed the presence 
of a second set of pur homologous genes (forV, forR, forC, and forD) involved in the 
adenosine biosynthetic pathway. Given the structural resemblance of formycin A to 
adenosine, a similar pathway for the assembly of pyrazolopyrimidine moiety of formycin 
A was proposed, which includes carboxyaminopyrazole ribonucleotide (128) as a pathway 
intermediate. The putative biosynthetic gene cluster of formycin A was identified by 
screening a cosmid library to locate pur-like genes, and bioinformatics analysis of the 
entire gene cluster allowed a biosynthetic pathway of formycin A to be proposed. The 
enzymatic conversion of 128 to formycin A 5′-phosphate (78) except the formyl transfer 
step was demonstrated to be catalyzed by ForV, ForR, ForC, and ForD as proposed. 
Moreover, the specificity of ForD toward formycin B 5′-phosphate (77) over the closely 
related substrate IMP (125) was examined by a competition experiment, which showed 
that ForD exhibits 9-fold selectivity toward 77. These observations strongly support the 
identification of a biosynthetic gene cluster specific for formycin A. Although no 
biochemical characterization has been realized yet, several enzymes that are proposed to 
catalyze early steps leading to the formation of intermediate 128 are being actively studied. 
In addition, a reductase encoded in close proximity to the formycin A gene cluster was 
found to be likely involved in the biosynthesis of coformycin (108), which is another 
nucleoside antibiotic possessing cooperative bioactivities. The discovery of a biosynthetic 
gene cluster for formycin A highlights a possible evolutionary link between a primary and 
a secondary metabolic pathway. A complete understanding of the biosynthetic pathway of 
formycin A and the enzymatic reaction mechanisms will shed light on the biosynthesis of 
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C-nucleosides, which also paves the way for repurposing of the pathway to develop new 
antibiotics.      
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